A method for using plant heterosis
Patent Information
- Application Number
- LAP737
- Authority / Receiving Office
- LA · LA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-03-06
- Filing Date
- 2019-03-06
- Publication Date
- 2022-11-04
AI Technical Summary
Existing technologies make it difficult to achieve large-scale production of hybrid seeds when utilizing the heterosis of hermaphroditic crops such as rice and wheat. Furthermore, traditional methods suffer from low seed production efficiency, high costs, and unstable purity of hybrid seeds.
By using gene mutation or genetic engineering techniques to transform the meiotic division of the reproductive cells of hybrids into a mitotic-like process, and by using the MTL protein to influence the development of plant gametes or embryos, the preparation of cloned seeds or plants of hybrids can be achieved, including knocking out the REC8, OSD1, PAIR1 and MTL genes.
It has enabled the preparation of cloned seeds or plants with consistent genotype and chromosome ploidy in hybrids, solving the problems of hybridization difficulties and low seed production caused by inconsistent flowering time, and improving seed production efficiency and the stability of hybrids.
Smart Images

Figure 00000000_0000_ABST 
Figure 00000000_0001_ABST
Abstract
Description
A method for utilizing plant heterosis Technical Field
[0001] This invention relates to the field of biotechnology, and more specifically, to a method for utilizing plant heterosis. Background Technology
[0002] Heterosis refers to the phenomenon in the biological world where, when two varieties with different genetic backgrounds or closely related species are crossed, the offspring of the hybrid exhibit superior traits in growth vigor, vitality, adaptability, and yield compared to their parents. Heterosis is a common phenomenon in the biological world and is widely used in crop breeding and production practices.
[0003] One of the most crucial aspects of applying heterosis in agricultural production is the efficient preparation of hybrid seeds. In dioecious crops like maize, male flowers of the maternal inbred line can be removed manually (or mechanically), and hybrid seeds can be obtained by pollination with pollen from another inbred line (the paternal parent). This process is relatively simple and easy, hence the early and mature utilization of heterosis in maize, leading to its widespread application. However, some parent lines have inconsistent flowering times, hindering large-scale hybrid seed production in the field.
[0004] However, hermaphroditic crops (such as rice and wheat) cannot achieve large-scale hybrid seed production by removing pollen from the female parent. Taking rice as an example: Currently, the approach to solving this problem in rice is to use plants with pollen sterility as the female parent and another variety as the male parent to provide pollen for hybridization, i.e., a hybrid vigor utilization system with male sterility as the core technology. The utilization of hybrid vigor in rice can be further divided into two technical approaches: one is the "three-line method" hybridization technology with nucleocytoplasmic interaction pollen sterility as the core technology; the other is the "two-line method" hybridization technology with photoperiod-temperature-sensitive nucleocytoplasmic sterility regulated by natural photoperiod and temperature as the core technology.
[0005] As shown in Figure 1A, the "three-line hybridization" technology involves: using a nucleocytoplasmic male sterile line as the female parent and a maintainer line as the male parent to mass-produce seeds that still retain sterility; and using the sterile line as the female parent and the restorer line as the male parent to mass-produce hybrid seeds that restore pollen fertility and have heterosis. These hybrid seeds are then used to produce hybrid rice.
[0006] As shown in Figure 1B, the "two-line hybridization" technique involves using the same rice line where the pollen is fertile under certain conditions to propagate sterile seeds; and using the sterility of the pollen under another specific condition to hybridize with the male parent to prepare hybrid seeds.
[0007] Because hybrid rice utilizes the superiority of the first generation of hybrids, segregation of traits or fertility will occur in subsequent generations. Therefore, seed production must be carried out every year, consuming a large amount of manpower, material resources, and land resources. In addition, the "three-line method" is constrained by the restoration and conservation relationship, resulting in low utilization of germplasm resources; the "two-line method" is affected by natural temperature and light, the reproductive yield of the sterile line is unstable, and there is a risk that low temperature induction of self-pollination of the sterile line during hybrid seed production may lead to substandard purity of hybrid seeds.
[0008] In addition, some related literature reports the utilization of heterosis and genes related to plant reproduction. For example, Turning rice meiosis into mitosis (Cell Research (2016) 26:1242-1254) discloses that F1 hybrids can be self-propagated and maintain superior traits through apomixis, in which the exogenously modified CENH3 gene was introduced through hybridization. US 2014 / 0298507 A1 discloses the conversion of apomixis into cloned embryos or seeds. The Journal of Sichuan University (Natural Science Edition), Vol.29 No.2 1992 discloses the application of apomixis in plant breeding and cell embryology research methods.
[0009] Summary of the Invention
[0010] The present invention aims to provide a method for utilizing plant heterosis to produce cloned seeds or plants from hybrids, thereby improving seed production efficiency.
[0011] To achieve the above objectives, according to one aspect of the present invention, a method for utilizing heterosis in plants is provided. The method includes the following steps: S1, using gene mutation or genetic engineering techniques to transform the meiotic division of the reproductive cells of a hybrid into a mitotic-like process to obtain gametes consistent with the genotype and chromosome ploidy of the hybrid; and S2, using gene mutation and genetic engineering techniques to influence processes involved in plant gamete or embryo development, wherein the protein involved is an MTL protein.
[0012] Furthermore, gene mutation includes random mutagenesis and directed mutagenesis; random mutagenesis includes chemical mutagenesis, physical mutagenesis, and biological mutagenesis; directed mutagenesis includes gene editing technology, which includes CRISPR / Cas gene editing technology, CRISPR / Cpf1 gene editing technology, TALEN gene editing technology, homing endonuclease gene editing technology, and ZFN gene editing technology; genetic engineering technology includes transgenic technology to induce specific expression, translocation expression, or gene silencing of genes.
[0013] Furthermore, S1 includes taking a hybrid and using gene mutation or genetic engineering technology to transform the meiotic division of its germ cells into a mitotic-like process, thereby obtaining gametes with the same genotype and chromosome ploidy as the hybrid.
[0014] Furthermore, S1 includes editing the parents of the hybrid using gene mutation or genetic engineering technology, then obtaining the hybrid through hybridization between the parents, and then obtaining hybrid gametes that transform germ cells into meiotic cells.
[0015] Furthermore, S1 includes using gene mutation or genetic engineering techniques to edit proteins involved in meiosis in plants to transform meiosis in germ cells into a mitotic-like process; wherein the proteins include a first protein, a second protein, and a third protein, wherein,
[0016] The first protein is a protein involved in the formation of DNA double-strand breaks. The first protein is selected from the following proteins:
[0017] Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR1 protein, such as the PAIR1 protein shown in SEQ ID NO:13; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR1 protein.
[0018] Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR2 protein, such as the PAIR2 protein shown in SEQ ID NO:14; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR2 protein.
[0019] Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR3 protein, such as the PAIR3 protein shown in SEQ ID NO:15; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR3 protein.
[0020] Proteins such as the PRD1 protein shown in SEQ ID NO:16, proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD1 protein, or proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD1 protein;
[0021] The PRD2 protein as shown in SEQ ID NO:17, and proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD2 protein, or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD2 protein;
[0022] Proteins such as the SPO11-1 protein shown in SEQ ID NO:18, proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-1 protein, or proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-1 protein;
[0023] Proteins such as the SPO11-2 protein shown in SEQ ID NO:19, proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-2 protein, or proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-2 protein;
[0024] The SDS protein shown in SEQ ID NO:20, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SDS protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SDS protein;
[0025] The CRC1 protein as shown in SEQ ID NO:21, and proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the CRC1 protein, or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the CRC1 protein;
[0026] P31 as shown in SEQ ID NO:22 comet Protein, and P31 comet Proteins with at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence identity, or proteins that are similar to P31. comet Proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity;
[0027] The MTOPVIB protein shown in SEQ ID NO:23, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTOPVIB protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTOPVIB protein;
[0028] The DFO protein as shown in SEQ ID NO:24, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the DFO protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the DFO protein;
[0029] The second protein is involved in controlling the adhesion between sister chromosomes during meiosis. The second protein is selected from the following proteins:
[0030] The REC8 protein shown in SEQ ID NO:25, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the REC8 protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the REC8 protein;
[0031] The third protein participates in the second meiotic division and is selected from the following proteins:
[0032] The OSD1 protein shown in SEQ ID NO:26, and proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the OSD1 protein, or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the OSD1 protein;
[0033] The TAM protein as shown in SEQ ID NO:27, and a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TAM protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TAM protein;
[0034] The TDM1 protein as shown in SEQ ID NO:28, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TDM1 protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TDM1 protein.
[0035] Furthermore, S2 includes using gene mutations and genetic engineering techniques to influence the process of plant gamete or embryo development, inducing gametes to develop into seeds or plants.
[0036] Furthermore, S2 includes inducing pollen from other plants to induce gametes to develop into seeds or plants.
[0037] Furthermore, S2 includes inducing gametes to develop into seeds or plants through physical stimulation, biological stress, or chemical treatment.
[0038] Furthermore, S2 includes inducing gametes to develop into seeds or plants through anther culture or pollen culture.
[0039] Further, the MTL protein is the MTL protein shown in SEQ ID NO:29, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTL protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTL protein.
[0040] Furthermore, plants include both monocots and dicots.
[0041] Furthermore, the plants include rice, corn, sorghum, millet, barley, wheat, rye, oats, buckwheat, Job's tears, sugarcane, asparagus, bamboo shoots, leeks, yams, soybeans, potatoes, peas, mung beans, adzuki beans, broad beans, cowpeas, kidney beans, lentils, mandarins, chickpeas, cassava, sweet potatoes, rapeseed, cotton, beets, eggplant, peanuts, tea, mint, coffee, sesame, sunflower, castor beans, perilla seeds, safflower, tomatoes, peppers, cucumbers, bok choy, lettuce, spinach, garlic, cabbage, mustard greens, water chestnuts, scallions, winter melon, zucchini, loofah, Chinese cabbage, radishes, onions, watermelons, grapes, carrots, cauliflower, pumpkins, tobacco, forage grass, elephant grass, foxtail grass, Sudan grass, orchids, lilies, tulips, and alfalfa.
[0042] According to another aspect of the invention, a plant or seed that retains heterosis is provided. This plant or seed is prepared by any of the methods described above.
[0043] According to another aspect of the invention, a kit is provided for maintaining heterosis in plants. The kit includes a carrier and / or reagent capable of converting meiosis in plant reproductive cells into mitosis-like processes, and a carrier and / or reagent for causing gametes to develop into seeds or plants.
[0044] Furthermore, the vector and / or reagent that enables the meiosis of plant reproductive cells to be transformed into a mitosis-like process is a vector and / or reagent that transforms the meiosis of hybrid reproductive cells into a mitosis-like process through gene mutation or genetic engineering technology, preferably a vector and / or reagent for random mutagenesis or directed mutagenesis.
[0045] Furthermore, random mutagenesis includes chemical mutagenesis, physical mutagenesis, and biological mutagenesis; directed mutagenesis includes CRISPR / Cas gene editing technology, CRISPR / Cpf1 gene editing technology, TALEN gene editing technology, homing endonuclease gene editing technology, and ZFN gene editing technology; genetic engineering technology includes transgenic technology to induce specific expression, translocation expression, or gene silencing of genes.
[0046] Furthermore, the vector and / or reagent capable of transforming meiosis in plant reproductive cells into a mitosis-like process involves editing proteins involved in meiosis in plants using gene mutation or genetic engineering techniques. These proteins include a first protein, a second protein, and a third protein.
[0047] The first protein is involved in the formation of DNA double-strand breaks. The first protein is selected from the following proteins:
[0048] Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR1 protein, such as the PAIR1 protein shown in SEQ ID NO:13; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR1 protein.
[0049] Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR2 protein, such as the PAIR2 protein shown in SEQ ID NO:14; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR2 protein.
[0050] Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR3 protein, such as the PAIR3 protein shown in SEQ ID NO:15; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR3 protein.
[0051] Proteins such as the PRD1 protein shown in SEQ ID NO:16, proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD1 protein, or proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD1 protein;
[0052] The PRD2 protein as shown in SEQ ID NO:17, and proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD2 protein, or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD2 protein;
[0053] Proteins such as the SPO11-1 protein shown in SEQ ID NO:18, proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-1 protein, or proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-1 protein;
[0054] Proteins such as the SPO11-2 protein shown in SEQ ID NO:19, proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-2 protein, or proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-2 protein;
[0055] The SDS protein shown in SEQ ID NO:20, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SDS protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SDS protein;
[0056] The CRC1 protein as shown in SEQ ID NO:21, and proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the CRC1 protein, or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the CRC1 protein;
[0057] P31 as shown in SEQ ID NO:22 comet Protein, and P31 comet Proteins with at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence identity, or proteins that are similar to P31. comet Proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity;
[0058] The MTOPVIB protein shown in SEQ ID NO:23, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTOPVIB protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTOPVIB protein;
[0059] The DFO protein as shown in SEQ ID NO:24, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the DFO protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the DFO protein;
[0060] The second protein is involved in controlling the adhesion between sister chromosomes during meiosis. The second protein is selected from the following proteins:
[0061] The REC8 protein shown in SEQ ID NO:25, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the REC8 protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the REC8 protein;
[0062] The third protein participates in the second meiotic division and is selected from the following proteins:
[0063] The OSD1 protein shown in SEQ ID NO:26, and proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the OSD1 protein, or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the OSD1 protein;
[0064] The TAM protein as shown in SEQ ID NO:27, and a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TAM protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TAM protein;
[0065] The TDM1 protein as shown in SEQ ID NO:28, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TDM1 protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TDM1 protein.
[0066] Furthermore, the carrier and / or reagent for inducing gametes to develop into seeds or plants includes a carrier and / or reagent for inducing gametes to develop into seeds or plants by influencing MTL proteins involved in the development of plant gametes or embryos using gene mutations or genetic engineering techniques, wherein the MTL protein is the MTL protein shown in SEQ ID NO:29, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence identity with the MTL protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity with the MTL protein.
[0067] According to another aspect of the invention, a plant produced using the above-described kit is provided. The meiotic division of the plant's reproductive cells transforms into a mitotic-like process, thereby producing gametes consistent with the genotype and chromosome ploidy of the hybrid.
[0068] Furthermore, plant gametes can be induced to develop into plants or seeds.
[0069] Furthermore, the plant is a genetically modified or genetically engineered plant. This modification utilizes gene mutations or genetic engineering techniques to regulate proteins involved in meiosis, transforming meiosis in reproductive cells into a process similar to mitosis. It also uses gene mutations or genetic engineering techniques to influence a fourth protein involved in gamete or embryo development, inducing gametes to develop into seeds or plants. These proteins include a first protein, a second protein, and a third protein.
[0070] The first protein is involved in the formation of DNA double-strand breaks. The first protein is selected from the following proteins:
[0071] Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR1 protein, such as the PAIR1 protein shown in SEQ ID NO:13; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR1 protein.
[0072] Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR2 protein, such as the PAIR2 protein shown in SEQ ID NO:14; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR2 protein.
[0073] Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR3 protein, such as the PAIR3 protein shown in SEQ ID NO:15; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR3 protein.
[0074] Proteins such as the PRD1 protein shown in SEQ ID NO:16, proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD1 protein, or proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD1 protein;
[0075] The PRD2 protein as shown in SEQ ID NO:17, and proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD2 protein, or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD2 protein;
[0076] Proteins such as the SPO11-1 protein shown in SEQ ID NO:18, proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-1 protein, or proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-1 protein;
[0077] Proteins such as the SPO11-2 protein shown in SEQ ID NO:19, proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-2 protein, or proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-2 protein;
[0078] The SDS protein shown in SEQ ID NO:20, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SDS protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SDS protein;
[0079] The CRC1 protein as shown in SEQ ID NO:21, and proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the CRC1 protein, or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the CRC1 protein;
[0080] P31 as shown in SEQ ID NO:22 comet Protein, and P31 cometProteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the P31comet protein;
[0081] The MTOPVIB protein shown in SEQ ID NO:23, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTOPVIB protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTOPVIB protein;
[0082] The DFO protein as shown in SEQ ID NO:24, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the DFO protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the DFO protein;
[0083] The second protein is involved in controlling the adhesion between sister chromosomes during meiosis. The second protein is selected from the following proteins:
[0084] The REC8 protein shown in SEQ ID NO:25, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the REC8 protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the REC8 protein;
[0085] The third protein participates in the second meiotic division and is selected from the following proteins:
[0086] The OSD1 protein shown in SEQ ID NO:26, and proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the OSD1 protein, or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the OSD1 protein;
[0087] Proteins that share at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity with TAM protein, such as the TAM protein shown in SEQ ID NO:27; or proteins that share at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity with TAM protein; as shown in SEQ ID NO:27. The TDM1 protein shown in NO:28, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TDM1 protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TDM1 protein;
[0088] Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to TDM1 protein, such as the TDM1 protein shown in SEQ ID NO:28; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to TDM1 protein.
[0089] The fourth protein is selected from the following proteins:
[0090] Proteins such as the MTL protein shown in SEQ ID NO:29, proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTL protein, or proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTL protein.
[0091] According to another aspect of the present invention, a method for maintaining heterosis in plants is provided. The method includes the following steps: S1, using gene editing technology to convert the meiotic division of germ cells in the F1 generation of a hybrid into a mitotic-like process to obtain diploid female gametes of the F1 generation; and S2, using gene mutation and genetic engineering techniques to influence processes involved in plant gamete or embryo development to induce the diploid female gametes to develop into seeds, wherein the protein involved is an MTL protein.
[0092] Furthermore, S1 includes taking F1 generation hybrid seeds and using gene editing technology to transform the meiosis of germ cells into a mitosis-like process to obtain diploid female gametes of the F1 generation.
[0093] Furthermore, S1 includes using gene editing technology to edit the parents of the hybrid to obtain plants in which all edited genes are heterozygous mutations, then obtaining hybrids by crossing the parents, screening the hybrids for plants in which multiple edited genes in both parents are homozygous mutations, and then obtaining diploid female gametes of the F1 generation that undergo meiosis similar to mitosis.
[0094] Furthermore, S1 involves using gene editing technology to knock out the REC8, OSD1, and PAIR1 genes to transform meiosis in germ cells into a mitotic-like process.
[0095] Furthermore, S2 includes inducing diploid female gametes to develop into seeds by pollinating them with haploid inducing lines of diploid female gametes.
[0096] Furthermore, S2 includes generating haploid inducible pollen lines by knocking out the MTL gene using gene editing technology.
[0097] Furthermore, S2 includes using haploid inducing pollen from other plants to induce diploid female gametes to develop into seeds.
[0098] Furthermore, the REC8, OSD1, PAIR1, and MTL genes were simultaneously knocked out in the F1 generation of the hybrid.
[0099] Furthermore, the plants include rice, corn, sorghum, millet, barley, and wheat.
[0100] By applying the technical solution of this invention, hybrid seeds can produce cloned seeds that are completely identical to their own genotype, enabling the hybrid seeds to be used for a long time. This solves the problems of difficulty in hybridization between parents, low seed production, and high cost of hybrid seeds caused by inconsistent flowering periods in the previous utilization of hybrid vigor. Attached Figure Description
[0101] The accompanying drawings, which form part of this application, are used to provide a further understanding of the invention. The illustrative embodiments of the invention and their descriptions are used to explain the invention and do not constitute an undue limitation of the invention. In the drawings:
[0102] Figure 1A shows a schematic diagram of the three-line hybridization breeding technology process in the prior art;
[0103] Figure 1B shows a schematic diagram of the two-line hybridization breeding technology process in the prior art;
[0104] Figures 2 and 3 show schematic diagrams illustrating the genotype retention of the F1 generation in this invention;
[0105] Figure 4A shows the cell ploidy detection results of the F1 generation plant Chunyou 84 in Example 1; and
[0106] Figure 4B shows the cell ploidy detection results of the heterotic fixed plants in Example 1.
[0107] Figure 5 shows the whole genome sequencing results of the male parent C84, the female parent 16A, the hybrid Chunyou 84 (CY84), and the genotype and chromosome ploidy fixed plants in Example 1. Detailed Implementation
[0108] It should be noted that, unless otherwise specified, the embodiments and features described in this application can be combined with each other. The present invention will now be described in detail with reference to the accompanying drawings and embodiments.
[0109] The technical terms used in this invention are explained as follows:
[0110] Heterosis refers to the phenomenon that the first generation of hybrids is superior to the parents in terms of body size, growth rate, fertility, and behavioral characteristics.
[0111] Meiosis: During the division of germ cells, chromosomes replicate only once, and the cell divides twice consecutively. This is a special type of division in which the number of chromosomes is halved.
[0112] Mitosis, also known as indirect division, was discovered in plants by E. Strasburger (1880). It is characterized by the appearance of spindle fibers and chromosomes during cell division, which allows the daughter chromosomes that have already been replicated in the S phase to be evenly distributed to the daughter cells. This type of division is common in higher plants and animals.
[0113] Chromosome ploidy refers to the number of chromosome sets or genomes contained in a cell, such as haploid staining and polyploid staining.
[0114] Diploid female gamete: Gamete refers to the mature sex cell produced by the reproductive system during sexual reproduction of an organism, also known as a reproductive cell. Gametes are divided into male gametes and female gametes. Normally, when a reproductive cell divides, the chromosomes replicate only once. The cell divides twice in succession, and the number of chromosomes is halved. However, if the number of chromosomes in a female gamete is not halved when it is generated, but is consistent with the number of chromosome sets in the somatic cells of the species, it is called a diploid female gamete.
[0115] Haploid: An individual or cell whose somatic cell chromosome number is equal to the number of gamete chromosome sets of the species.
[0116] Parthenogenesis, also known as asexual reproduction, refers to the process by which an egg develops into a normal new individual without fertilization.
[0117] In this invention, a hybrid refers to a plant or seed with a heterozygous genotype, whose offspring from sexual reproduction will undergo genetic segregation.
[0118] According to a typical embodiment of the present invention, a method for utilizing heterosis in plants is provided. The method includes the following steps: S1, using gene mutation or genetic engineering technology to transform the meiotic division of the reproductive cells of a hybrid into a mitotic-like process to obtain gametes with the same genotype and chromosome ploidy as the hybrid; and S2, using gene mutation and genetic engineering technology to influence the process involved in the development of plant gametes or embryos, wherein the protein involved is an MTL protein.
[0119] Among them, gene mutation includes random mutagenesis and directed mutagenesis; random mutagenesis includes chemical mutagenesis, physical mutagenesis and biological mutagenesis; directed mutagenesis includes gene editing technology, preferably CRISPR / Cas gene editing technology, CRISPR / Cpf1 gene editing technology, TALEN gene editing technology, homing endonuclease gene editing technology and ZFN gene editing technology; genetic engineering technology includes transgenic technology to induce specific expression, translocation expression or gene silencing of genes.
[0120] Specifically, common physical mutagenesis methods include: radiation (ultraviolet light, X-rays, gamma rays, neutron beams), laser microbeams, ion beams, microwaves, ultrasound, and heat. Common chemical mutagenesis methods include: immersion, application, dripping, injection, administration, and fumigation. Chemical mutagens include: alkylating agents, base analogs, lithium chloride, nitrosamines, azides, antibiotics, hydroxylamine, acridine, diethyl sulfate (DFS), 5-bromouracil (5-BU), nitrogen mustard (Nm), and N'-methyl-N'-nitrosoguanidine (NTG). Biological mutagenesis methods include: space-induced mutagenesis, pathogenic microorganism mutagenesis, tissue culture mutagenesis, and transgenic mutagenesis.
[0121] As an example application, one could be TILLING (Targeting Induced Local Mutations in Genomes, as described by McCallum et al., Plant Physiology, 2000, 123, 439-442). This involves targeted mutagenesis using standard techniques known in the art that utilize homologous recombination, preferably in combination with nucleases such as TALEN or CRISPR.
[0122] According to a typical embodiment of the present invention, the method includes the following steps: S1, using gene mutation or genetic engineering technology to transform the meiotic division of the reproductive cells of the hybrid into a mitotic-like process to obtain gametes with the same genotype and chromosome ploidy as the hybrid; and S2, inducing the gametes to develop into seeds or plants.
[0123] By applying the technical solution of this invention, hybrids can produce cloned seeds or plants that are completely identical to their own genotype, enabling hybrids to be used for a long time. This solves the problems of difficulty in hybridization between parents, low seed production, and high cost of hybrids caused by inconsistent flowering periods in the previous utilization of heterosis.
[0124] According to a typical embodiment of the present invention, S1 includes taking hybrid seeds and using gene mutation or genetic engineering technology to transform the meiotic division of their reproductive cells into a mitotic-like process, thereby obtaining gametes with the same genotype and chromosome ploidy as the hybrid seeds. For example, the specific operation may be: S1 includes taking F1 generation hybrid seeds and using genetic engineering technology to transform the meiotic division of reproductive cells into a mitotic-like process, thereby obtaining diploid gametes of the F1 generation. Specifically, the method may be: taking F1 generation hybrid seeds and editing key genes involved in meiosis using a gene editing system to obtain gene-edited F1 generation plants. The female gametes of the gene-edited F1 generation plants are diploid gametes. Preferably, the key genes involved in meiosis are REC8, OSD1, and PAIR1.
[0125] According to a typical embodiment of the present invention, S1 includes editing the parents of the hybrid using gene mutation or genetic engineering technology, then obtaining a hybrid through hybridization between the parents, and subsequently obtaining hybrid gametes whose reproductive cells undergo meiosis and transform into mitosis-like processes. For example, the specific operation may be: S1 includes editing the parents of the hybrid using genetic engineering technology to obtain a heterozygous mutant in which all key genes involved in meiosis are in a heterozygous mutant state, then obtaining a hybrid through hybridization between the parents, screening plants in the hybrid in which all key genes involved in meiosis are homozygous mutants, and subsequently obtaining diploid female gametes of the F1 generation whose reproductive cells undergo meiosis and transform into mitosis-like processes. The specific method can be as follows: Take the male and female parents of the hybrid, respectively, and edit the three key genes involved in meiosis by introducing a gene editing system to obtain parent plants in which the three genes are all heterozygous after gene editing. Then, cross these two parents, and the resulting seeds will have different genotypes. Select the seeds in which the three genes are all homozygous mutations. Such plants are the F1 generation seeds that this invention aims to obtain. The female gametes of the F1 generation seeds are diploid female gametes.
[0126] According to a typical embodiment of the present invention, S1 includes using gene mutation or genetic engineering techniques to edit proteins involved in meiosis in plants to transform meiosis in germ cells into a mitosis-like process; wherein the proteins include a first protein, a second protein, and a third protein, wherein,
[0127] The first protein is involved in the formation of DNA double-strand breaks. The first protein is selected from the following proteins:
[0128] Such as SEQ ID NO:13(MKLKMNKACDIASISVLPPRRTGGSSGASASGSVAVAVASQPRSQPLSQSQQSFSQGASASLLHSQSQFSQVSLDDNLLTLLPSPTRDQRFGLHDDSSKRMSSLPASSASCAREESQLQLAKLPSNPVHRWNPSIADTRSGQVTNEDVERKFQHLASSVH KMGMVVDSVQSDVMQLNRAMKEASLDGSIRQKIAVLESSLQQILKGQDDLKALFGSSTKHNPDQTSVLNSLGSKLNEISSTLATLQTQMQARQLQGDQTTVLNSNASKSNEISSTLATLQTQMQADIRQLRCDVFRVFTKEMEGVVRAIRSVNSRPAAMQMMADQS The PAIR1 protein shown in YQVPVSNGWTQINQTPVAAGRSPMNRAPVAAGRSRMNQLPETKVLSAHLVYPAKVTDLKPKVEQGKVKAAPQKPFASSYYRVAPKQEEVAIRKVNIQVPAKKAPVSIIIESDDDSEGRASCVILKTETGSKEWKVTKQGTEEGLEILRRARKRRRREMQSIVLAS) is a protein that has at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PAIR1 protein, or a protein that has at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PAIR1 protein.
[0129] Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR2 protein, such as the PAIR2 protein shown in SEQ ID NO:14(); or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR2 protein.
[0130] The PAIR3 protein as shown in SEQ ID NO:15 (MEVELTNIQKATSSDYWSLASNQYPCGKFPKVSVGVTIPRTSSVSRGRDAASTAAFEKNLSQGTDGRSRPPKMDNASLQVSPEAANHGGSAKEVPKPVPAKVSVSQPDDNAIEQTGTFSFGTRREQDSHLDQLDRPPLVSSQGKRQVESADKNKPNSEMLRMKLWEILGGTSQNKEAVASPNPEDIETPCQPKSQIANGPSSGRQKVFTSPVPYNIKTPAQFNSQTANKPSS DPIESDSDSPQVVEVRPITRSLGRKKEPTGSTHQDKSGSAKKPLSTHRSTPKQKILDNVFAFNDKCTPKTVGKSANGESGSLRNLRSLSRRAKVEPKKAHCSDRISHKTTQDDMERKVPSKYIPSEKKGEKTNSFSSLSRTGKTAESCSRSPKRERRVNTMANVGARKMQLSENLLVKTLNDGEHKLSSPQLTSFKSKGKCSSISPQQKENDNTHIPEASDRTAARNSFNSTPSPAANPSPVLRKYSWEHDENPAINGKSGQKDASPLADRFSDMPDDFASPTFAANIKISPHRSKMLDDDLFSSKYPKGVNRSRSTSFTSDPESEPLDKMEKTNELPGSESPNSQEERQNRKQPHLSPLSPIESEGAQISIPSFRKGYKSHKWLSDVDSPDKSSIEHLGRKSHLKEGRKGKRQLTSPTHFATSGTQETMSDKEPEKVPENYLTRAFDQLVVVLGRFQTKIKSETRNKSSKILAATGEIIRQHLEGVEGQMQADVDKLVNAGKSKRKRLESTFEEQQEKLRILHEKFKEEVNQQLLGCKNSVEDFEAYHAELKGVADKQKASHKKLLQNAEKTVGAQLSDAETKIAEVQKRARKRMKGLKFVLKELIAETAE), a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 98% sequence identity with the PAIR3 protein,Or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PAIR3 protein;
[0131]
[0132] Such as SEQ ID NO:17(MAPPASRPPTPTPTPTANAAASSSRIESPSLRAALAMALIHYNRLPSRAAAAAAPSPQALLNWKRKAKDRKREILRLREELKLLQDGARGEEMEPPVASCRCHFFDGCGDLPPPTDGDAGEHWVDDVLRRRFVRLVRWKDKRRRL DRSLPTSSLMEYNTEDEVQQLSLSIDFLVELSDGLFAKREAGSSFTTFSHQAVDFILASLKNILSSEREKEIIEEIINGLVARLMKRMCTTPENAGSVDCSDAQFSLQHLFRKLGNEEFVGQRIILAISQKISNVSEKLLLADPFDDGFPE The PRD2 protein shown in MHSNMFIMIQLIEFLISDSFNNWLCRDHFDRKLFEEWVRSILKARKDLEVLDGRNGLYVVYIERVIGRLAREVAPAAHQGKLDLEVLSKLLY) is a protein that has at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD2 protein;
[0133] Such as SEQ ID NO:18(MAGREKRRRVAALDGEERRRRQEEAATLLHRIRGLVRWVVAEVAAGRSPTVALHRYQNYCSSASAAAASPCACSYDVPVGTDVLSLLHRGSHASRLNVLLRVLLVVQQLLQQNKHCSKRDIYYMYPSIFQEQAV VDRAINDICVLFKCSRHNLNVVPVAKGLVMGWIRFLEGEKEVYCVTNVNAAFSIPVSIEAIKDVVSVADYILIVEKETVFQRLANDKFCERNRCIVITGRGYPDIPTRFRYLVEQLHLPVYCLVDADPYGFDILATYK The SPO11-1 protein shown in FGSLQLAYDANFLRVPDIRWLGVFTSDFEDYRLPDCCLLHLSSEDRRKAEGILSRCYLHREAPQWRLELEAMLQKGVKFEIEALSACSISFLSEEYIPKKIKQGRHI) is a protein that has at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-1 protein, or a protein that has at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-1 protein.
[0134] Such as SEQ ID NO:19(MAEAGVAAASLFGADRRLCSADILPPAEVRARIEVAVLNFLAALTDPAAPAISALPLISRGAANRGLRRALLRDDVSSVYLSYASCKRSLTRANDAKAFVRVWKVMEMCYKILGEGKLVTLRELFYTLLSESPTY FTCQRHVNQTVQDVVSLLRCTRQSLGIMASSRGALIGRLVVQGPEEEHVDCSILGPSGHAITGDLNVLSKLIFSSDARYIIVVEKDAIFQRLAEDRIYSHLPCILITAKGYPDLATRFILHRLSQTYPNMPIFALVDWNPA The SPO11-2 protein shown in GLAILCTYKYGSISMGLESYRYACNVKWLGLRGDDLQLIPQSAYQELKPRDLQIAKSLLSSKFLQDKHRAELTLMLETGKRAEIEALYSHGFDFLGKYVARKIVQGDYI) is a protein that has at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-2 protein, or a protein that has at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-2 protein.
[0135] Such as SEQ ID NO:20(MPPTMLASVPTRPRSHPFRRRRGAAAAAPPLLPDQIAAAAAAAKRPAESSTSASSCFHSEVISATSTTTCPTSLAAAQRPEKRPRYQDVDEEQPAASECSEIIGGARPRAAEVEVSESSCLASVLESYLACPEQLANDAETTAYSSAREDLTL SETEEEEEEEEVRSGPCICTDCSFSPLHESSSSSDDDNAVPSPPTSLLFLALAEQFVPFTHPKTPTATDVALQAGEGKRFEDLDNEVSYERFRRRERRGVVARDYIEVYSSMLGSYGRAVVEQRVVMVNWIMEHSQAMKLQPETVFMGIGLMDRFLTRGY The SDS protein shown in VKGSRNLQLLGIACTTLATRIEENQPYNCILQKAFKVGINTYSRSEVVAMEWLVQEVLDFQCFVTTTHHFLWFYLKAANADDRVEDLAKYLALLSLLDHKHLSFWPSTVAAAVVALACLATNNESSCHLVMETHMRTKNDDLPECLMSLEWLTNYAS) is a protein that has at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SDS protein, or a protein that has at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SDS protein.
[0136] For example, SEQ ID NO:21(MSAPMEVSFSAPPPPDAASAAAAAPSLVPAVSAAAVAATTVSCSPQPPTGSPSADDRILVSVEVLLHATSTARAEDVCAAVERMLEARSLSYVDGPVPIPNDDPFLLANVKRIQICDTDEWTENHKVLLFWQVRPVVHVFQLSEDGPGEEPGEDDTLSSFNEWALPAK EFDGLWESLLYEVGLKQRLLRYAASALLFTEKGVDPCLVSWNRIVLLHGPPTGKTSLCKALAQKLSIRFKSRYSMCQLIEVNAHSLFSKWFSESGKLVAKLFQKIQEMVEEESNLVF VLIDEVESLAAARQAAISGSEPSDSIRVVNALLTQMDKLKSWPNVIILTTSNITTAIDIAFVDRADIKAYVGPPTLQARYEILRSCLQELLRVGILTHTQGGNSLCLLSYFSLMENQH The CRC1 protein shown in CPEVADPHGSVHLSGLLHKAAEICEGLSGRTLRKLPFLAHASVANPSCCDASAFLHALIQTAQRELSESRG) is a protein that has at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the CRC1 protein, or a protein that has at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the CRC1 protein.
[0137] Such as SEQ ID NO:22(MERATTSGGGGGGSQPPRGVGLPLVEVQAAAASLRRSEVFYVVKELLGFVLYMHHQIPAVLQNLENEFASLKEEMTEMALPPGEMKPSDQRKYNTRKREVRRRIKKQEKLMNGLSSVFSALQKALDEVPSIEGVLLILGGSLV P31 shown in cometProtein, and P31 comet Proteins with at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence identity, or proteins that are similar to P31. comet Proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity;
[0138] Such as SEQ ID NO:23(MASSPPPSTASPTSSSPYRKLLHSLIYWAVQRCRMSESPCRLTVSVKRSPEPAGSSPLRISVSDTGVGSKLEEFLELDALARETPVEKWDGTLLITTTGIDDKAIYRYQFNLQEDTSSSTRFTKLATMYKSRAIFSGTEVCLCLPTEADVDDLILWLVGF VRKIFVLRASNLACELFVAQTDSASGDVCLSQDSDDVHISITTSSIDRLVSGLKDYALSHANTSDRCEACYMNRDRLKIGTGTAKYVDKRKAKGQLVEVVIMIAPTSSDLSCWMTNCSSTQVLHFVEFIPCPISQSSLSALMSIDWQSYGFKFKGGFIDDDGNAEL The MTOPVIB protein shown in QWDNMAFSHVDIAIHTYHEGAVDEWKSSQPERHLLRKALKSALFGLKADHAEDFLSCHGQKVREYVPDLAESIAGLILSSNDQEFQDECIALLGLGSDQDLTEGAVRSCIGEKMNRIIEMNDTKENVEHNAPYLFECERFDEDYSLLDEDDPDEDMIFDF) is a protein that has at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTOPVIB protein;
[0139] Such as SEQ ID NO:24(MRHNIKFKSKGTLKIRNTAQISLWKKCSDSMIADQTYLFINRVQDRRFDEESLRILELSLLVAMNVKSFLEVRSRLRDFMRSESVVIFGELTGESMVAKLSVLEFFARAFALLGDMESCLAMRYEALNLRQLKSPSCLWLGVSHSEWTKFAVQSMENGFPSIAGKASENALLSLKKDSLIEPKSEDNSDILDAAE The DFO protein shown in KVRRLRDSAASLTSSHSGIFIYIVSSLKFAVCNRLLTTF) is a protein that has at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the DFO protein, or a protein that has at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the DFO protein.
[0140] The second protein is involved in controlling the adhesion between sister chromosomes during meiosis. The second protein is selected from the following proteins:
[0141] The REC8 protein as shown in SEQ ID NO:25(), a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the REC8 protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the REC8 protein;
[0142] The third protein participates in the second meiotic division and is selected from the following proteins:
[0143] For example, SEQ ID NO:26(MPEVRNSGGRAALADPSGGGFFIRRTTSPPGAVAVKPLARRALPPTSNKENVPPSWAVTVRATPKRRSPLPEWYPRSPLRDITSVVKAVERKSRLGNAAVRQQIQLSEDSSRSVDPATPVQKEEGVPQSTPTPPTQKALDAAAPCPGSTQAVASTSTAYLAEGKPKASSSSPSDCSFQTPSRPNDPALADLMEKEL The OSD1 protein shown in SSSIEQIEKMVRKNLKRAPKAAQPSKVTIQKRTLLSMR) is a protein that has at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the OSD1 protein, or a protein that has at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the OSD1 protein.
[0144] Such as SEQ ID NO:27(MSSSSSRNLSQENPIPRPNLAKTRTSLRDVGNRRAPLGDITNQKNGSRNPSPSSTLVNCSNKIGQSKKAPKPALSRNWNLGILDSGLPPKPNAKSNIIVPYEDTELLQSDDSLLCSSPALSLDASPTQSDPSISTHDSLTNHVVDYM VESTTDDGNDDDDEIVNIDSDLMDPQLCASFACDIYEHLRVSEVNKRPALDYMERTQSSINASMRSILIDWLVEVAEEYRLSPETLYLAVNYVDRYLTGNAINKQNLQLLGVTCMMIAAKYEEVCVPQVEDFCYITDNTYLRNELLEMESSV The TAM protein shown in LNYLKFELTTPTAKCFLRRFLRAAQGRKEVPSLLSECLACYLTELSLLDYAMLRYAPSLVAASAVFLAQYTLHPSRKPWNATLEHYTSYRAKHMEACVKNLLQLCNEKLSSDVVAIRKKYSQHKYKFAAKKLCPTSLPQELFL) is a protein that has at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TAM protein, or a protein that has at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TAM protein.
[0145] Such as SEQ ID NO:28(MCPCVERRAPPGVYYTPPPARTSDHVAAMPMTERRRPPYSCSSSSERRDPFHIVHKVPSGDSPYVRAKHAQLIDKDPNRAISLFWTAINAGDRVDSALKDMAVVMKQLGRSDEGIEAIKSFRYLCSFESQDSIDNLLLELYKK SGRIEEEAVLLEHKLQTLEQGMGFGGRVSRAKRVQGKHVIMTIEQEKARILGNLGWVHLQLHNYGIAEQHYRFGFVTKIPNIDYCLVMRALGLERDKNKLCNLAICLMRMSRIPEAKSLLDDVRDSPAESECGDEPFAKSYDRAVEMLA The TDM1 protein shown in EIESKKPEADLSEKFYAGCSFVNRMKENIAPGTANKNYSDVSSSPASVRPNSAGLYTQPRRCRLFEEETRGAARKLLFGKPQPFGSEQMKILERGEEEPMKRKKLDQNMIQYLHEFVKDTADGPKSESKKSWADIAEEEEAEEEEEERLQGELKTAEM) is a protein that has at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TDM1 protein, or a protein that has at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TDM1 protein.
[0146] Among them, the PAIR1 protein is involved in the initiation of meiotic recombination and catalyzes the formation of DNA double-strand gaps. The deletion of the PAIR1 gene will lead to the absence of the recombination process. The REC8 protein is responsible for tightly linking the newly replicated sister chromosomes together. It is a key regulatory factor that ensures the correct separation and distribution of sister (or homologous) chromosomes into daughter cells. Its loss of function will cause the sister chromatids to separate at the end of the first meiotic division and move to opposite poles of the cell. The loss of function of the OSD1 gene will cause the formation of gametes to skip the second meiotic division process.
[0147] Knocking out the aforementioned genes is a simple and effective method to transform meiosis in germ cells into a mitosis-like process.
[0148] The inhibitory protein described in this invention refers to the protein whose activity is partially or completely lost by mutagenesis of the gene encoding the protein or its promoter, including by expressing silencing RNA in plants to obtain inhibition of the relevant protein.
[0149] According to a typical embodiment of the present invention, S2 includes influencing the process of gamete or embryo development in plants using gene mutation and genetic engineering techniques to induce gametes to develop into seeds or plants. Alternatively, S2 may include inducing gametes to develop into seeds or plants by presenting them with induced pollen from other plants; for example, S2 includes inducing diploid female gametes to develop into seeds by presenting them with haploid inducing lines of diploid female gametes; or, S2 may include inducing gametes to develop into seeds or plants through physical stimulation, biological stress, or chemical treatment; or, S2 may include inducing gametes to develop into seeds or plants through anther culture or pollen culture.
[0150] Preferably, the MTL protein is as SEQ ID NO:29(MAASYSCRRTCEACSTRAMAGCVVGEPASAPGQRVTLLAIDGGGIRGLIPGTILAFLEARLQELDGPDARLADYFDCIAGTSTGGLITAMLAAPGDHGRPLFAASDINRFYLDNGPLIFPQKRCGMAAAMAALTRPRYNGKYLQG KIRKMLGETRVRDTLTNVVIPTFDVRLLQPTIFSTYDAKSMPLKNALLSDICISTSAAPTYLPAHCFQTTDDATGKVREFDLIDGGVAANNPTMVAMTQITKKIMVKDKEELYPVKPSDCGKFLVLSVGTGSTSDQGMYTARQCSRWGIVR The MTL protein shown in WLRNKGMAPIIDIFMAASSDLVDIHAAVMFQSLHSDGDYLRIQDNTLHGDAATVDAATRDNMRALVGIGERMLAQRVSRVNVETGRYVEVPGAGSNADALRGFARQLSEERRARLGRRNACGGGGEGEPSGVACKR) is a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTL protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTL protein. The induced pollen can come from plants that produce gametes with the same genotype and ploidy as the hybrid, or it can come from other plants. Preferably, the induced pollen comes from plants that produce female gametes with the same genotype and ploidy as the hybrid, which is achieved by simultaneously knocking out the REC8, OSD1, PAIR1 and MTL genes in the hybrid.
[0151] According to a typical embodiment of the present invention, the plants include monocotyledonous plants and dicotyledonous plants; preferably, the plants include rice, corn, sorghum, millet, barley, wheat, rye, oats, buckwheat, Job's tears, sugarcane, asparagus, bamboo shoots, leeks, yams, soybeans, potatoes, peas, mung beans, adzuki beans, broad beans, cowpeas, kidney beans, lentils, mandarins, chickpeas, cassava, sweet potatoes, rapeseed, cotton, beets, eggplant, peanuts, tea, mint, coffee, sesame, sunflower, castor beans, perilla seeds, safflower, tomatoes, peppers, cucumbers, bok choy, lettuce, spinach, garlic, cabbage, mustard greens, water chestnuts, scallions, winter melon, zucchini, loofah, Chinese cabbage, radishes, onions, watermelons, grapes, carrots, cauliflower, pumpkins, tobacco, forage grass, elephant grass, foxtail grass, Sudan grass, orchids, lilies, tulips, and alfalfa.
[0152] The implementation principle of this application is as follows:
[0153] The principle behind this application for apomixis is to directly form an embryo and produce seeds by bypassing meiosis and fertilization, which mainly involves two steps:
[0154] Step 1: Meiosis is a special cell division process that occurs in plants and animals during their reproductive period. During meiosis, genetic information from the parents is recombined, producing gametes with half the number of chromosomes.
[0155] When genes involved in three different important stages of plant meiosis are mutated simultaneously (this three-mutated material is named MiMe, Mitosis instead of Meiosis), the plant's meiosis will transform into a process similar to mitosis.
[0156] The number of chromosomes and genotypes in the female and male gamete cells produced by MiMe plants are completely identical to those in somatic cells. Their self-crossed offspring are all tetraploids with heterozygous genotypes, proving that by simultaneously mutating three genes, hybrid plants can bypass the meiotic division process and produce clonal gametes with the same genotype as somatic cells.
[0157] Step 2: The pollen-specific phospholipase gene (MATRILINEAL, MTL) primarily functions in the male gamete of plants and is the gene controlling haploid induction. It was first cloned in maize. Haploid induction material (mtl) can be obtained by knocking out the MTL gene. During double fertilization, the genome of the mtl male gamete in the zygote is degraded, meaning the paternal sperm nucleus does not form a zygote with the recipient egg nucleus, thus inducing haploid egg set.
[0158] Therefore, by simultaneously modifying the four endogenous genes MiMe and MTL in plants, Fix (Fixation of Hybrids) materials capable of apomixis were obtained. This means that by bypassing meiosis and fertilization, the maternal genome was preserved, resulting in diploid cells with genotypes completely identical to the parents. This demonstrates that by simultaneously modifying four endogenous genes, apomixis characteristics can be introduced into hybrid plants, thereby achieving the fixation of heterozygous genotypes.
[0159] According to a typical embodiment of the present invention, the method includes the following steps: 1) Transforming meiosis during gamete formation into a mitosis-like process. Studies have found that when the three genes REC8, OSD1, and PAIR1 involved in meiosis are simultaneously knocked out (this material is named MiMe, Mitosis instead of Meiosis), chromosomes replicate once, and the reproductive cells divide once instead of twice. The resulting gametes do not have a halved chromosome number, remaining consistent with somatic cells. That is, meiosis is transformed into a mitosis-like process, achieving chromosome doubling; 2) The resulting female gametes are stimulated by pollen that can induce their development, meaning the female gametes develop into embryos without fusing with sperm chromosomes, forming seeds with a genotype completely identical to that of somatic cells. Knocking out the MTL gene yields pollen that induces haploid production. Using hybrid seeds as the transgenic background, the REC8, OSD1, PAIR1, and MTL genes are simultaneously knocked out using gene mutation or genetic engineering techniques. The female gametes produced by this plant have the same chromosome ploidy as somatic cells. Furthermore, due to the destruction of the MTL gene, the pollen produced can induce the female gametes to develop into seeds or plants. In this way, the resulting seeds or plants do not undergo gene segregation (segregation of traits or fertility), and their genotypes are exactly the same as those of the mother cell (the background material for transgenic hybrids), ultimately achieving the goal of fixing heterosis.
[0160] Figures 2 and 3 clearly show that the F1 offspring genotypes and chromosome ploidy of the present invention are consistent with those of the hybrid mother cells.
[0161] According to a typical implementation, a plant or seed that retains heterosis is provided. The plant or seed is prepared by any of the methods described above, and the seed effectively immobilizes hybrid vigor.
[0162] According to a typical embodiment, a kit for maintaining heterosis in plants is provided. The kit includes a vector and / or reagent capable of inducing meiosis in plant reproductive cells to resemble mitosis, and a vector and / or reagent for inducing gametes to develop into seeds or plants. Preferably, the vector and / or reagent capable of inducing meiosis in plant reproductive cells to resemble mitosis and the vector and / or reagent for inducing parthenogenesis in plant gametes are vectors and / or reagents for random mutagenesis or directed mutagenesis. Random mutagenesis includes chemical mutagenesis, physical mutagenesis, and biological mutagenesis; directed mutagenesis includes CRISPR / Cas gene editing technology, CRISPR / Cpf1 gene editing technology, TALEN gene editing technology, homing endonuclease gene editing technology, and ZFN gene editing technology; genetic engineering techniques include transgenic technology to induce specific gene expression, translocation expression, or gene silencing.
[0163] According to a typical implementation, a carrier and / or reagent capable of transforming meiosis in plant reproductive cells into a mitosis-like process utilizes genetic engineering techniques to inhibit proteins involved in meiotic recombination in plants. This carrier and / or reagent transforms meiosis in reproductive cells into a mitosis-like process. The proteins include a first protein, a second protein, and a third protein.
[0164] The first protein is involved in the formation of DNA double-strand breaks. The first protein is selected from the following proteins:
[0165] Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR1 protein, such as the PAIR1 protein shown in SEQ ID NO:13; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR1 protein.
[0166] Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR2 protein, such as the PAIR2 protein shown in SEQ ID NO:14; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR2 protein.
[0167] Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR3 protein, such as the PAIR3 protein shown in SEQ ID NO:15; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR3 protein.
[0168] Proteins such as the PRD1 protein shown in SEQ ID NO:16, proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD1 protein, or proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD1 protein;
[0169] Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PRD2 protein, such as the PRD2 protein shown in SEQ ID NO:17; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PRD2 protein.
[0170] Proteins such as the SPO11-1 protein shown in SEQ ID NO:18, proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-1 protein, or proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-1 protein;
[0171] Proteins such as the SPO11-2 protein shown in SEQ ID NO:19, proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-2 protein, or proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-2 protein;
[0172] The SDS protein shown in SEQ ID NO:20, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SDS protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SDS protein;
[0173] The CRC1 protein as shown in SEQ ID NO:21, and proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the CRC1 protein, or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the CRC1 protein;
[0174] P31 as shown in SEQ ID NO:22 comet Protein, and P31 comet Proteins with at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence identity, or proteins that are similar to P31. comet Proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity;
[0175] The MTOPVIB protein shown in SEQ ID NO:23, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTOPVIB protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTOPVIB protein;
[0176] The DFO protein as shown in SEQ ID NO:24, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the DFO protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the DFO protein;
[0177] The second protein is involved in controlling the adhesion between sister chromosomes during meiosis. The second protein is selected from the following proteins:
[0178] The REC8 protein shown in SEQ ID NO:25, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the REC8 protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the REC8 protein;
[0179] The third protein participates in the second meiotic division and is selected from the following proteins:
[0180] The OSD1 protein shown in SEQ ID NO:26, and proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the OSD1 protein, or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the OSD1 protein;
[0181] The TAM protein as shown in SEQ ID NO:27, and a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TAM protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TAM protein;
[0182] The TDM1 protein as shown in SEQ ID NO:28, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TDM1 protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TDM1 protein.
[0183] Furthermore, the carrier and / or reagent for inducing gametes to develop into seeds or plants includes a carrier and / or reagent for inducing gametes to develop into seeds or plants by influencing MTL proteins involved in the development of plant gametes or embryos using gene mutations or genetic engineering techniques, wherein the MTL protein is the MTL protein shown in SEQ ID NO:29, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence identity with the MTL protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity with the MTL protein.
[0184] For ease of sale and use, preferably, the kit contains a vector and / or reagent for simultaneously knocking out the REC8, OSD1, PAIR1 and MTL genes in hybrids.
[0185] According to a typical embodiment, a plant is provided. The meiotic division of the plant's reproductive cells transforms into a mitotic-like process, thereby producing gametes with genotype and chromosome ploidy consistent with those of a hybrid; for example, the meiotic division of the plant's reproductive cells transforms into a mitotic-like process, thereby producing gametes with chromosome ploidy and genotype consistent with those of a hybrid. Preferably, the plant is capable of inducing gametes to develop into plants or seeds.
[0186] According to a typical implementation method, the plant is a genetically modified or genetically engineered plant. The plant utilizes gene mutations or genetic engineering techniques to regulate proteins involved in meiosis, thereby transforming meiosis in reproductive cells into a mitotic-like process. It also utilizes gene mutations or genetic engineering techniques to influence MTL proteins involved in gamete development, inducing gametes to develop into seeds or plants. These proteins include a first protein, a second protein, and a third protein.
[0187] The first protein is involved in the formation of DNA double-strand breaks. The first protein is selected from the following proteins:
[0188] Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR1 protein, such as the PAIR1 protein shown in SEQ ID NO:13; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR1 protein.
[0189] Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR2 protein, such as the PAIR2 protein shown in SEQ ID NO:14; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR2 protein.
[0190] Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR3 protein, such as the PAIR3 protein shown in SEQ ID NO:15; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to PAIR3 protein.
[0191] Proteins such as the PRD1 protein shown in SEQ ID NO:16, proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD1 protein, or proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD1 protein;
[0192] The PRD2 protein as shown in SEQ ID NO:17, and proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD2 protein, or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD2 protein;
[0193] Proteins such as the SPO11-1 protein shown in SEQ ID NO:18, proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-1 protein, or proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-1 protein;
[0194] Proteins such as the SPO11-2 protein shown in SEQ ID NO:19, proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-2 protein, or proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-2 protein;
[0195] The SDS protein shown in SEQ ID NO:20, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SDS protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SDS protein;
[0196] The CRC1 protein as shown in SEQ ID NO:21, and proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the CRC1 protein, or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the CRC1 protein;
[0197] P31 as shown in SEQ ID NO:22 comet Protein, and P31 comet Proteins with at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence identity, or proteins that are similar to P31. comet Proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity;
[0198] The MTOPVIB protein shown in SEQ ID NO:23, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTOPVIB protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTOPVIB protein;
[0199] The DFO protein as shown in SEQ ID NO:24, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the DFO protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the DFO protein;
[0200] The second protein is involved in controlling the adhesion between sister chromosomes during meiosis. The second protein is selected from the following proteins:
[0201] The REC8 protein shown in SEQ ID NO:25, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the REC8 protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the REC8 protein;
[0202] The third protein participates in the second meiotic division and is selected from the following proteins:
[0203] The OSD1 protein shown in SEQ ID NO:26, and proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the OSD1 protein, or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the OSD1 protein;
[0204] Proteins that share at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity with TAM protein, such as the TAM protein shown in SEQ ID NO:27; or proteins that share at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity with TAM protein; as shown in SEQ ID NO:27. The TDM1 protein shown in NO:28, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TDM1 protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TDM1 protein;
[0205] Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to TDM1 protein, such as the TDM1 protein shown in SEQ ID NO:28; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to TDM1 protein.
[0206] MTL protein is the MTL protein shown in SEQ ID NO:29, or a protein that has at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTL protein, or a protein that has at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTL protein.
[0207] The beneficial effects of the present invention will be further illustrated below with reference to the embodiments. Steps or reagents not described in detail in the following embodiments can be implemented using conventional techniques or reagents in the art.
[0208] Example 1
[0209] 1. In this embodiment, the F1 hybrid used is the approved and commercialized hybrid rice variety Chunyou 84. Chunyou 84 is a new interspecific hybrid rice combination bred by crossing the early-flowering late-japonica sterile line Chunjiang 16A with the indica-japonica intermediate wide-compatibility restorer line C84. This hybrid rice has advantages such as high yield potential, high seed production, excellent comprehensive agronomic traits, good resistance to blast, and wide adaptability. The genetic transformation background material used in this embodiment is callus induced from hybrid rice F1 seeds, which has not undergone a sexual reproduction stage. Therefore, the transgenic T0 generation material obtained after transgenic transformation is genetically consistent with the hybrid rice F1 plants.
[0210] 2. Construction of multi-gene knockout vectors.
[0211] The main steps are as follows (for details, please refer to CN201510485573.2):
[0212] 1) Construction of a single target SK-gRNA:
[0213] The following four sites were selected as the sites for knocking out REC8, OSD1, PAIR1, and MTL in the CRISPR-Cas9 gene editing system (underlined PAM sequences):
[0214] OSD1 gene knockout site (SEQ ID NO: 1): CTGCCGCCGACGAGCAACAAGG
[0215] PAIR1 gene knockout site (SEQ ID NO: 2): AAGCAACCCAGTGCACCGCTGG
[0216] REC8 gene knockout site (SEQ ID NO: 3): CCCATGGCACTAAGGCTCTCCG
[0217] MTL gene knockout site (SEQ ID NO: 4): GGTCAACGTCGAGACCGGCAGG
[0218] Design two complementary DNA sequences: add GGCA before the forward sequence and add AAAC before the reverse complementary sequence;
[0219] The SK-gRNA has two AarI restriction sites. After digestion with AarI, a vector with sticky ends is formed. After denaturation and annealing of the forward and reverse primers of the designed target sequence, the T4 ligase is used to ligate it into the previously constructed intermediate vector SK-gRNA to form a single target gRNA.
[0220] 2) Concatenation of multiple gRNAs and construction of the final binary expression vector:
[0221] Utilizing the isosinetic nature of BglII and BamHI, NheI and XbaI, and SalI and XhoI, gRNA polymerization was performed: SK-gRNA OSD1 was digested with KpnI and XhoI to serve as a vector; SK-gRNA PAIR1 was digested with SalI and XbaI to provide the PAIR1 sgRNA fragment; SK-gRNA REC8 was digested with NheI and BamHI to provide the REC8 sgRNA fragment; and SK-gRNA MTL was digested with BglII and KpnI to provide the MTL sgRNA fragment. This one-step rapid polymerization of up to four gRNAs was then performed. Finally, the polymerized gRNAs OSD1-gRNA, REC8-gRNA, and PAIR1-gRNA were synthesized. The MTL fragment was digested with KpnI and BglII and the fragment was recovered and ligated into the binary vector pC1300-Cas9 (between the KpnI and BamHI sites) expressing Cas9 protein, finally obtaining the multi-gene knockout vector pC1300-Cas9-gRNA OSD1-gRNA REC8-gRNA PAIR1-gRNA MTL, which can simultaneously knock out four genes: REC8, OSD1, PAIR1 and MTL. This vector was used to prepare multiple mutant rice transgenic strains.
[0222] 3. Obtaining transgenic plants.
[0223] The binary expression vector pC1300-Cas9-gRNA OSD1-gRNA REC8-gRNA PAIR1-gRNA MTL, containing multiple gene knockout, was transferred into the Agrobacterium tumefaciens strain EHA105 via electroporation. This vector was then transferred into the callus of rice variety Chunyou 84 using Agrobacterium-mediated transformation. Specifically, the embryos of Chunyou 84 hybrid rice seeds were sterilized and inoculated into a callus-inducing medium. After one week of culture, vigorous, light-yellow, and relatively loose embryogenic callus tissue was selected as the recipient for transformation. Rice callus tissue was infected with EHA105 strain containing the pC1300-Cas9-gRNA OSD1-gRNA REC8-gRNA PAIR1-gRNA MTL plasmid. After culturing at 25°C in the dark for 3 days, resistant callus tissue and transgenic plants were screened on a selection medium containing 50 mg / L hygromycin. Transgenic plants that grow normally on hygromycin selective medium were selected.
[0224] 4. Sequencing to identify the four mutants
[0225] Molecular biology techniques were used to identify mutations in the target gene. Genomic DNA was extracted from single transgenic plants using the CTAB method, and the target band was amplified by PCR. Primer pairs used:
[0226] OSD1-F (SEQ ID NO: 5):atctccaggatgcctgaagtgag
[0227] OSD1-R (SEQ ID NO: 6):cctagactgctactcttgctagtgat
[0228] PAIR1-F (SEQ ID NO: 7):ctgtacctgtgcatctaattacag
[0229] PAIR1-R (SEQ ID NO: 8):ccccatctttgtactgagcttgccag
[0230] REC8-F (SEQ ID NO: 9):gcgacgcttcactcgaagatca
[0231] REC8-R (SEQ ID NO: 10): cgccatgcctcgttgatctcaa
[0232] MTL-F (SEQ ID NO: 11):acagtgactagtgacaaacgatcg
[0233] MTL-R (SEQ ID NO: 12):gatcgcgtcagcatgatgcgtgtac
[0234] The obtained PCR products were sent to a sequencing company for sequencing using OSD1-F, PAIR1-F, REC8-F, and MTL-F primers, respectively. The results were compared with wild-type sequences. For sequencing results with bimodal peaks, degenerate codon strategy analysis (http: / / dsdecode.scgene.com / for peak plot analysis) was used to directly obtain mutation information. From this, four tetramutants, each with biallelic mutations, were screened out.
[0235] 5. Identify plants with fixed ploidy and genotype in the F1 generation.
[0236] 1) Among the F1 plants of the identified four mutant plants, flow cytometry was used to screen for cell ploidy, and the selected plants had cell ploidy consistent with that of the parent plant.
[0237] The specific method is as follows:
[0238] Take a certain amount of plant tissue and place it in a glass culture dish. Add 1-2 ml of plant lysis buffer LB01 and chop it with a blade (this operation should always be performed on ice). Aspirate the lysis solution from the culture dish and filter it through a 50 μm nylon mesh into a centrifuge tube. Centrifuge at 1200 rpm and 4 °C for 5 min. Discard the supernatant and add 450 μl of LB01, 25 μL of pre-chilled PI (1 mg / ml), and RNase A (1 mg / ml). Stain in the dark for 10 min and then analyze the staining results to screen for diploid plants.
[0239] Figure 4A shows the cell ploidy test results of F1 generation plant Chunyou 84; and Figure 4B shows the cell ploidy test results of heterotic fixed plants.
[0240] 2) Whole genome sequencing.
[0241] Leaves from two parental lines, Chunjiang 16A and C84, Chunyou 84, and four randomly selected F1 plants with fixed ploidy were extracted for whole-genome sequencing. The whole-genome sequencing results (Figure 5) showed that many different homozygous genotypes existed between Chunjiang 16A and C84. The hybrid Chunyou 84 exhibited heterozygous genotypes at these loci, showing a combination of both Chunjiang 16A and C84 genotypes. The genotypes of the four selected plants were identical to those of Chunyou 84, indicating a heterozygous state. This molecular biological evidence confirms that the genotypes are completely identical to those of the hybrid mother cells.
[0242] Example 2
[0243] 1. In this embodiment, the maintainer line Chunjiang 16B and the intermediate indica-japonica wide-compatibility restorer line C84 were used. The genetic transformation background material used in this embodiment was callus obtained by induction from parental seeds.
[0244] 2. Construction of multi-gene knockout vectors.
[0245] The main steps are as follows:
[0246] 1) Construction of a single target SK-gRNA:
[0247] The following four sites were selected as the sites for knocking out REC8, OSD1, PAIR1, and MTL in the CRISPR-Cas9 gene editing system (underlined PAM sequences):
[0248] OSD1 gene knockout site (SEQ ID NO: 1): CTGCCGCCGACGAGCAACAAGG
[0249] PAIR1 gene knockout site (SEQ ID NO: 2): AAGCAACCCAGTGCACCGCTGG
[0250] REC8 gene knockout site (SEQ ID NO: 3): CCCATGGCACTAAGGCTCTCCG
[0251] MTL gene knockout site (SEQ ID NO: 4): GGTCAACGTCGAGACCGGCAGG
[0252] Design two complementary DNA sequences: add GGCA before the forward sequence and add AAAC before the reverse complementary sequence;
[0253] The SK-gRNA has two AarI restriction sites. After digestion with AarI, a vector with sticky ends is formed. After denaturation and annealing of the forward and reverse primers of the designed target sequence, the T4 ligase is used to ligate it into the previously constructed intermediate vector SK-gRNA to form a single target gRNA.
[0254] 4) Concatenation of multiple gRNAs and construction of the final binary expression vector:
[0255] Utilizing the isosinetic nature of BglII and BamHI, NheI and XbaI, and SalI and XhoI, gRNA polymerization was performed: SK-gRNA OSD1 was digested with KpnI and XhoI to serve as a vector; SK-gRNA PAIR1 was digested with SalI and XbaI to provide the PAIR1 sgRNA fragment; SK-gRNA REC8 was digested with NheI and BamHI to provide the REC8 sgRNA fragment; and SK-gRNA MTL was digested with BglII and KpnI to provide the MTL sgRNA fragment. This one-step rapid polymerization of up to four gRNAs was then performed. Finally, the polymerized gRNAs OSD1-gRNA, REC8-gRNA, and PAIR1-gRNA were synthesized. The MTL fragment was digested with KpnI and BglII and the fragment was recovered and ligated into the binary vector pC1300-Cas9 (between the KpnI and BamHI sites) expressing Cas9 protein, finally obtaining the multi-gene knockout vector pC1300-Cas9-gRNA OSD1-gRNA REC8-gRNA PAIR1-gRNA MTL, which can simultaneously knock out four genes: REC8, OSD1, PAIR1 and MTL. This vector was used to prepare multiple mutant rice transgenic strains.
[0256] 3. Obtaining transgenic plants.
[0257] The binary expression vector pC1300-Cas9-gRNA OSD1-gRNA REC8-gRNA PAIR1-gRNA MTL, containing multiple gene knockout, was transferred into the Agrobacterium tumefaciens strain EHA105 via electroporation. This vector was then transferred into calluses of Chunjiang 16B and C84 using Agrobacterium-mediated transformation. Specifically, after sterilizing the seed embryos, the seeds were inoculated into a callus-inducing medium. After one week of culture, vigorous, light yellow, and relatively loose embryogenic calluses were selected as recipients for transformation. Rice callus was infected with EHA105 strain containing the pC1300-Cas9-gRNA OSD1-gRNA REC8-gRNA PAIR1-gRNA MTL plasmid. After culturing at 25°C in the dark for three days, resistant callus and transgenic plants were screened on a selection medium containing 50 mg / L hygromycin. Transgenic plants that grow normally on hygromycin selective medium were selected.
[0258] 4. Sequencing was used to identify Chunjiang 16B and C84 materials with heterozygous mutations in all four genes. Hybridization was then performed, and hybrid plants with mutations in all four genes were selected from the progeny.
[0259] Molecular biology techniques were used to identify mutations in the target gene. Genomic DNA was extracted from single transgenic plants using the CTAB method, and the target band was amplified by PCR. Primer pairs used:
[0260] OSD1-F (SEQ ID NO: 5):atctccaggatgcctgaagtgag
[0261] OSD1-R (SEQ ID NO: 6):cctagactgctactcttgctagtgat
[0262] PAIR1-F (SEQ ID NO: 7):ctgtacctgtgcatctaattacag
[0263] PAIR1-R (SEQ ID NO: 8):ccccatctttgtactgagcttgccag
[0264] REC8-F (SEQ ID NO: 9):gcgacgcttcactcgaagatca
[0265] REC8-R (SEQ ID NO: 10): cgccatgcctcgttgatctcaa
[0266] MTL-F (SEQ ID NO: 11):acagtgactagtgacaaacgatcg
[0267] MTL-R (SEQ ID NO: 12):gatcgcgtcagcatgatgcgtgtac
[0268] The obtained PCR products were sent to a sequencing company and sequenced using OSD1-F, PAIR1-F, REC8-F, and MTL-F as sequencing primers, respectively. The results were compared with the wild-type sequence to directly obtain mutation information.
[0269] After screening for heterozygous mutant Chunjiang 16B and C84 materials, they were crossbred and hybrid plants with bis-allelic mutations were screened out in the F1 generation.
[0270] 5. Collect seeds from hybrid plants and identify plants with fixed ploidy and genotypes in the F1 generation.
[0271] 1) Among the F1 plants of the identified 3 mutant plants, cell ploidy was screened by flow cytometry, and the selected plants had cell ploidy consistent with that of the parent plants.
[0272] The specific method is as follows:
[0273] Take a certain amount of plant tissue and place it in a glass culture dish. Add 1-2 ml of plant lysis buffer LB01 and chop it with a blade (this operation should always be performed on ice). Aspirate the lysis solution from the culture dish and filter it through a 50 μm nylon mesh into a centrifuge tube. Centrifuge at 1200 rpm and 4 °C for 5 min. Discard the supernatant and add 450 μl of LB01, 25 μL of pre-chilled PI (1 mg / ml), and RNase A (1 mg / ml). Stain in the dark for 10 min and then analyze the staining results to screen for diploid plants.
[0274] 2) Whole genome sequencing.
[0275] Leaves from two parental lines, Chunjiang 16B and C84, Chunyou 84, and two randomly selected F1 plants with fixed ploidy were extracted for whole-genome sequencing. The sequencing results showed that many different homozygous genotypes existed between Chunjiang 16B and C84. The hybrid Chunyou 84 exhibited heterozygous genotypes at these loci, showing a combination of both Chunjiang 16B and C84 genotypes. The two selected plants also showed heterozygous genotypes, consistent with Chunyou 84, demonstrating molecular biological evidence that their genotypes were completely identical to those of the hybrid mother cells.
[0276] Example 3
[0277] 1. In this embodiment, the F1 hybrid used is the approved and commercialized hybrid rice variety Chunyou 84. Chunyou 84 is a new interspecific hybrid rice combination bred by crossing the male-sterile line Chunjiang 16A with the intermediate wide-compatibility restorer line C84 between indica and japonica rice. This hybrid rice has advantages such as high yield potential, high seed production, excellent comprehensive agronomic traits, good resistance to blast, and wide adaptability. The genetic transformation background material used in this embodiment is callus induced from hybrid rice F1 seeds, which has not undergone a sexual reproduction stage. Therefore, the transgenic T0 generation material obtained after transgenic transformation is genetically consistent with the hybrid rice F1 plants.
[0278] 2. Construction of multi-gene knockout vectors.
[0279] The main steps are as follows:
[0280] 1) Construction of a single target SK-gRNA:
[0281] The following three sites were selected as the sites for knocking out REC8, OSD1, and PAIR1 in the CRISPR-Cas9 gene editing system (underlined PAM sequences):
[0282] OSD1 gene knockout site (SEQ ID NO: 1): CTGCCGCCGACGAGCAACAAGG
[0283] PAIR1 gene knockout site (SEQ ID NO: 2): AAGCAACCCAGTGCACCGCTGG
[0284] REC8 gene knockout site (SEQ ID NO: 3): CCCATGGCACTAAGGCTCTCCG
[0285] Design two complementary DNA sequences: add GGCA before the forward sequence and add AAAC before the reverse complementary sequence;
[0286] The SK-gRNA has two AarI restriction sites. After digestion with AarI, a vector with sticky ends is formed. After denaturation and annealing of the forward and reverse primers of the designed target sequence, the T4 ligase is used to ligate it into the previously constructed intermediate vector SK-gRNA to form a single target gRNA.
[0287] 2) Concatenation of the three gRNAs and construction of the final binary expression vector:
[0288] Utilizing the isosinetic nature of BglII and BamHI, NheI and XbaI, and SalI and XhoI, gRNA was polymerized. The polymerized gRNA OSD1-gRNA REC8-gRNA PAIR1 fragment was then digested with KpnI and BglII and the fragment was recovered and ligated into the binary vector pC1300-Cas9 (between the KpnI and BamHI sites) expressing Cas9 protein. This yielded the multi-gene knockout vector pC1300-Cas9-gRNA OSD1-gRNA REC8-gRNA PAIR1, capable of simultaneously knocking out REC8, OSD1, and PAIR1 genes, which was used for transgenic rice multi-mutant production.
[0289] 3. Obtaining transgenic plants.
[0290] The binary expression vector pC1300-Cas9-gRNA OSD1-gRNA REC8-gRNA PAIR1-gRNA, containing multiple gene knockouts, was transferred into the Agrobacterium tumefaciens strain EHA105 via electroporation. This vector was then transferred into the callus of rice variety Chunyou 84 using Agrobacterium-mediated transformation. Specifically, the embryos of Chunyou 84 hybrid rice seeds were sterilized and inoculated into a callus-inducing medium. After one week of culture, vigorous, light yellow, and relatively loose embryogenic callus tissue was selected as the recipient for transformation. Rice callus tissue was infected with EHA105 strain containing the pC1300-Cas9-gRNA OSD1-gRNA REC8-gRNA PAIR1 plasmid. After culturing at 25°C in the dark for 3 days, resistant callus tissue and transgenic plants were screened on a selection medium containing 50 mg / L hygromycin. Transgenic plants that grow normally on hygromycin selective medium were selected.
[0291] 4. Sequencing to identify triple mutants
[0292] Molecular biology techniques were used to identify mutations in the target gene. Genomic DNA was extracted from single transgenic plants using the CTAB method, and the target band was amplified by PCR. Primer pairs used:
[0293] OSD1-F (SEQ ID NO: 5):atctccaggatgcctgaagtgag
[0294] OSD1-R (SEQ ID NO: 6):cctagactgctactcttgctagtgat
[0295] PAIR1-F (SEQ ID NO: 7):ctgtacctgtgcatctaattacag
[0296] PAIR1-R (SEQ ID NO: 8):ccccatctttgtactgagcttgccag
[0297] REC8-F (SEQ ID NO: 9):gcgacgcttcactcgaagatca
[0298] REC8-R (SEQ ID NO: 10): cgccatgcctcgttgatctcaa
[0299] The obtained PCR products were sent to a sequencing company and sequenced using OSD1-F, PAIR1-F, and REC8-F primers, respectively. The results were compared with the wild-type sequence. For sequencing results with bimodal peaks, peak plot analysis using a degenerate codon strategy (http: / / dsdecode.scgene.com / ) directly yielded mutation information.
[0300] Among them, all three sites are biallelic mutants, which are plants that can produce gametes with the same genotype and chromosome ploidy as somatic cells.
[0301] 5. Using the triple mutant as the female parent, pollinate it with pollen from other haploid inducing lines to induce female gametes to develop into seeds, thereby obtaining a large number of hybrid varieties that maintain heterosis.
[0302] 6. Identify plants with fixed ploidy and genotype in the F1 generation.
[0303] 1) Among the F1 plants of the identified triple mutant plants, flow cytometry was used to screen for cell ploidy, and the selected plants had cell ploidy consistent with that of the parent plants.
[0304] The specific method is as follows:
[0305] Take a certain amount of plant tissue and place it in a glass culture dish. Add 1-2 ml of plant lysis buffer LB01 and chop it with a blade (this operation should always be performed on ice). Aspirate the lysis solution from the culture dish and filter it through a 50 μm nylon mesh into a centrifuge tube. Centrifuge at 1200 rpm and 4 °C for 5 min. Discard the supernatant and add 450 μl of LB01, 25 μL of pre-chilled PI (1 mg / ml), and RNase A (1 mg / ml). Stain in the dark for 10 min and then analyze the staining results to screen for diploid plants.
[0306] 2) Whole genome sequencing.
[0307] Leaves from two parental lines, Chunjiang 16A and C84, Chunyou 84, and four randomly selected F1 plants with fixed ploidy were extracted for whole-genome sequencing. The sequencing results showed that many different homozygous genotypes existed between Chunjiang 16A and C84. The hybrid Chunyou 84 exhibited heterozygous genotypes at these loci, showing a combination of both Chunjiang 16A and C84 genotypes. The four selected plants also showed heterozygous genotypes, consistent with Chunyou 84, demonstrating molecular biological evidence that their genotypes were completely identical to those of the hybrid mother cells.
[0308] Example 4
[0309] 1. In this embodiment, the F1 hybrid used is the approved and commercialized hybrid rice variety Chunyou 84. Chunyou 84 is a new interspecific hybrid rice combination bred by crossing the male-sterile line Chunjiang 16A with the intermediate wide-compatibility restorer line C84 between indica and japonica rice. This hybrid rice has advantages such as high yield potential, high seed production, excellent comprehensive agronomic traits, good resistance to blast, and wide adaptability. The genetic transformation background material used in this embodiment is callus induced from hybrid rice F1 seeds, which has not undergone a sexual reproduction stage. Therefore, the transgenic T0 generation material obtained after transgenic transformation is genetically consistent with the hybrid rice F1 plants.
[0310] 2. Construction of multi-gene knockout vectors.
[0311] The main steps are as follows:
[0312] 1) Construction of a single target SK-gRNA:
[0313] The following three sites were selected as the sites for knocking out REC8, OSD1, and PAIR1 in the CRISPR-Cas9 gene editing system (underlined PAM sequences):
[0314] OSD1 gene knockout site (SEQ ID NO: 1): CTGCCGCCGACGAGCAACAAGG
[0315] PAIR1 gene knockout site (SEQ ID NO: 2): AAGCAACCCAGTGCACCGCTGG
[0316] REC8 gene knockout site (SEQ ID NO: 3): CCCATGGCACTAAGGCTCTCCG
[0317] Design two complementary DNA sequences: add GGCA before the forward sequence and add AAAC before the reverse complementary sequence;
[0318] The SK-gRNA has two AarI restriction sites. After digestion with AarI, a vector with sticky ends is formed. After denaturation and annealing of the forward and reverse primers of the designed target sequence, the T4 ligase is used to ligate it into the previously constructed intermediate vector SK-gRNA to form a single target gRNA.
[0319] 2) Concatenation of the three gRNAs and construction of the final binary expression vector:
[0320] Utilizing the isosinetic nature of BglII and BamHI, NheI and XbaI, and SalI and XhoI, gRNA was polymerized. The polymerized gRNA OSD1-gRNA REC8-gRNA PAIR1 fragment was then digested with KpnI and BglII and the fragment was recovered and ligated into the binary vector pC1300-Cas9 (between the KpnI and BamHI sites) expressing Cas9 protein. This yielded the multi-gene knockout vector pC1300-Cas9-gRNA OSD1-gRNA REC8-gRNA PAIR1, capable of simultaneously knocking out REC8, OSD1, and PAIR1 genes, which was used for transgenic rice multi-mutant production.
[0321] 3. Obtaining transgenic plants.
[0322] The binary expression vector pC1300-Cas9-gRNA OSD1-gRNA REC8-gRNA PAIR1-gRNA MTL, containing multiple gene knockout, was transferred into the Agrobacterium tumefaciens strain EHA105 via electroporation. This vector was then transferred into the callus of rice variety Chunyou 84 using Agrobacterium-mediated transformation. Specifically, the embryos of Chunyou 84 hybrid rice seeds were sterilized and inoculated into a callus-inducing medium. After one week of culture, vigorous, light yellow, and relatively loose embryogenic callus tissue was selected as the recipient for transformation. Rice callus tissue was infected with EHA105 strain containing the pC1300-Cas9-gRNA OSD1-gRNA REC8-gRNA PAIR1 plasmid. After culturing at 25°C in the dark for 3 days, resistant callus tissue and transgenic plants were screened on a selection medium containing 50 mg / L hygromycin. Transgenic plants that grow normally on hygromycin selective medium were selected.
[0323] 4. Sequencing to identify triple mutants
[0324] Molecular biology techniques were used to identify mutations in the target gene. Genomic DNA was extracted from single transgenic plants using the CTAB method, and the target band was amplified by PCR. Primer pairs used:
[0325] OSD1-F (SEQ ID NO: 5):atctccaggatgcctgaagtgag
[0326] OSD1-R (SEQ ID NO: 6):cctagactgctactcttgctagtgat
[0327] PAIR1-F (SEQ ID NO: 7):ctgtacctgtgcatctaattacag
[0328] PAIR1-R (SEQ ID NO: 8):ccccatctttgtactgagcttgccag
[0329] REC8-F (SEQ ID NO: 9):gcgacgcttcactcgaagatca
[0330] REC8-R (SEQ ID NO: 10): cgccatgcctcgttgatctcaa
[0331] The obtained PCR products were sent to a sequencing company and sequenced using OSD1-F, PAIR1-F, and REC8-F primers, respectively. The results were compared with the wild-type sequence. For sequencing results with bimodal peaks, peak plot analysis using a degenerate codon strategy (http: / / dsdecode.scgene.com / ) directly yielded mutation information.
[0332] Among them, all three sites are biallelic mutants, which are plants that can produce gametes with the same genotype and chromosome ploidy as somatic cells.
[0333] 5. After the three mutants developed to a certain stage, anthers or pollen were aseptically collected and inoculated onto artificially prepared anther culture medium to induce callus formation, and then plants were obtained through tissue culture.
[0334] 6. Identify ploidy and genotype-fixed plants in tissue culture.
[0335] 1) Among the F1 plants of the identified 3 mutant plants, cell ploidy was screened by flow cytometry, and the selected plants had cell ploidy consistent with that of the parent plants.
[0336] The specific method is as follows:
[0337] Take a certain amount of plant tissue and place it in a glass culture dish. Add 1-2 ml of plant lysis buffer LB01 and chop it with a blade (this operation should always be performed on ice). Aspirate the lysis solution from the culture dish and filter it through a 50 μm nylon mesh into a centrifuge tube. Centrifuge at 1200 rpm and 4 °C for 5 min. Discard the supernatant and add 450 μl of LB01, 25 μL of pre-chilled PI (1 mg / ml), and RNase A (1 mg / ml). Stain in the dark for 10 min and then analyze the staining results to screen for diploid plants.
[0338] 2) Whole genome sequencing.
[0339] Leaves from two parental lines, Chunjiang 16A and C84, Chunyou 84, and four randomly selected F1 plants with fixed ploidy were extracted for whole-genome sequencing. The sequencing results showed that many different homozygous genotypes existed between Chunjiang 16A and C84. The hybrid Chunyou 84 exhibited heterozygous genotypes at these loci, showing a combination of both Chunjiang 16A and C84 genotypes. The four selected plants also showed heterozygous genotypes, consistent with Chunyou 84, demonstrating molecular biological evidence that their genotypes were completely identical to those of the hybrid mother cells.
[0340] Example 5
[0341] 1. In this embodiment, the F1 hybrid used is the approved and commercialized hybrid rice variety Chunyou 84. Chunyou 84 is a new interspecific hybrid rice combination bred by crossing the male-sterile line Chunjiang 16A with the intermediate wide-compatibility restorer line C84 between indica and japonica rice. This hybrid rice has advantages such as high yield potential, high seed production, excellent comprehensive agronomic traits, good resistance to blast, and wide adaptability. The genetic transformation background material used in this embodiment is callus induced from hybrid rice F1 seeds, which has not undergone a sexual reproduction stage. Therefore, the transgenic T0 generation material obtained after transgenic transformation is genetically consistent with the hybrid rice F1 plants.
[0342] 2. Construction of multi-gene knockout vectors.
[0343] The main steps are as follows:
[0344] 1) Construction of a single target SK-gRNA:
[0345] The following three sites were selected as the sites for knocking out REC8, OSD1, and PAIR1 in the CRISPR-Cas9 gene editing system (underlined PAM sequences):
[0346] OSD1 gene knockout site (SEQ ID NO: 1): CTGCCGCCGACGAGCAACAAGG
[0347] PAIR1 gene knockout site (SEQ ID NO: 2): AAGCAACCCAGTGCACCGCTGG
[0348] REC8 gene knockout site (SEQ ID NO: 3): CCCATGGCACTAAGGCTCTCCG
[0349] Design two complementary DNA sequences: add GGCA before the forward sequence and add AAAC before the reverse complementary sequence;
[0350] The SK-gRNA has two AarI restriction sites. After digestion with AarI, a vector with sticky ends is formed. After denaturation and annealing of the forward and reverse primers of the designed target sequence, the T4 ligase is used to ligate it into the previously constructed intermediate vector SK-gRNA to form a single target gRNA.
[0351] 2) Concatenation of the three gRNAs and construction of the final binary expression vector:
[0352] Utilizing the isosinetic nature of BglII and BamHI, NheI and XbaI, and SalI and XhoI, gRNA was polymerized. The polymerized gRNA OSD1-gRNA REC8-gRNA PAIR1 fragment was then digested with KpnI and BglII and the fragment was recovered and ligated into the binary vector pC1300-Cas9 (between the KpnI and BamHI sites) expressing Cas9 protein. This yielded the multi-gene knockout vector pC1300-Cas9-gRNA OSD1-gRNA REC8-gRNA PAIR1, capable of simultaneously knocking out REC8, OSD1, and PAIR1 genes, which was used for transgenic rice multi-mutant production.
[0353] 3. Obtaining transgenic plants.
[0354] The binary expression vector pC1300-Cas9-gRNA OSD1-gRNA REC8-gRNA PAIR1-gRNA MTL, containing multiple gene knockout, was transferred into the Agrobacterium tumefaciens strain EHA105 via electroporation. This vector was then transferred into the callus of rice variety Chunyou 84 using Agrobacterium-mediated transformation. Specifically, the embryos of Chunyou 84 hybrid rice seeds were sterilized and inoculated into a callus-inducing medium. After one week of culture, vigorous, light yellow, and relatively loose embryogenic callus tissue was selected as the recipient for transformation. Rice callus tissue was infected with EHA105 strain containing the pC1300-Cas9-gRNA OSD1-gRNA REC8-gRNA PAIR1 plasmid. After culturing at 25°C in the dark for 3 days, resistant callus tissue and transgenic plants were screened on a selection medium containing 50 mg / L hygromycin. Transgenic plants that grow normally on hygromycin selective medium were selected.
[0355] 4. Sequencing to identify triple mutants
[0356] Molecular biology techniques were used to identify mutations in the target gene. Genomic DNA was extracted from single transgenic plants using the CTAB method, and the target band was amplified by PCR. Primer pairs used:
[0357] OSD1-F (SEQ ID NO: 5):atctccaggatgcctgaagtgag
[0358] OSD1-R (SEQ ID NO: 6):cctagactgctactcttgctagtgat
[0359] PAIR1-F (SEQ ID NO: 7):ctgtacctgtgcatctaattacag
[0360] PAIR1-R (SEQ ID NO: 8):ccccatctttgtactgagcttgccag
[0361] REC8-F (SEQ ID NO: 9):gcgacgcttcactcgaagatca
[0362] REC8-R (SEQ ID NO: 10): cgccatgcctcgttgatctcaa
[0363] The obtained PCR products were sent to a sequencing company and sequenced using OSD1-F, PAIR1-F, and REC8-F primers, respectively. The results were compared with the wild-type sequence. For sequencing results with bimodal peaks, peak plot analysis using a degenerate codon strategy (http: / / dsdecode.scgene.com / ) directly yielded mutation information.
[0364] Among them, all three sites are biallelic mutants, which are plants that can produce gametes with the same genotype and chromosome ploidy as somatic cells.
[0365] 5. Chemically induced parthenogenesis
[0366] Rice materials with the REC8, OSD1, and PAIR1 genes simultaneously knocked out were selected. Before flowering, the rice panicles were pruned and the males killed using standard hybridization techniques. The panicles were then immersed in a treatment solution of 5–50 mg / L maleic hydrazine or 2–20 mg / L 6-benzylaminopurine for 2–3 minutes, and tightly bagged to prevent pollen entry. Twenty days after treatment, immature embryos or grains were cultured to obtain parthenogenetic plants.
[0367] 6. Identify plants with fixed ploidy and genotype in the F1 generation.
[0368] 1) Among the F1 plants of the identified triple mutant plants, flow cytometry was used to screen for cell ploidy, and the selected plants had cell ploidy consistent with that of the parent plants.
[0369] The specific method is as follows:
[0370] Take a certain amount of plant tissue and place it in a glass culture dish. Add 1-2 ml of plant lysis buffer LB01 and chop it with a blade (this operation should always be performed on ice). Aspirate the lysis solution from the culture dish and filter it through a 50 μm nylon mesh into a centrifuge tube. Centrifuge at 1200 rpm and 4 °C for 5 min. Discard the supernatant and add 450 μl of LB01, 25 μL of pre-chilled PI (1 mg / ml), and RNase A (1 mg / ml). Stain in the dark for 10 min and then analyze the staining results to screen for diploid plants.
[0371] 2) Whole genome sequencing.
[0372] Leaves from two parental lines, Chunjiang 16A and C84, Chunyou 84, and four randomly selected F1 plants with fixed ploidy were extracted for whole-genome sequencing. The sequencing results showed that many different homozygous genotypes existed between Chunjiang 16A and C84. The hybrid Chunyou 84 exhibited heterozygous genotypes at these loci, showing a combination of both Chunjiang 16A and C84 genotypes. The four selected plants also showed heterozygous genotypes, consistent with Chunyou 84, demonstrating molecular biological evidence that their genotypes were completely identical to those of the hybrid mother cells.
[0373] Example 6
[0374] 1. Mutant mutagenesis and screening
[0375] In soybean variety Zhonghuang 39, EMS mutagenesis was used to screen offspring for heterozygous mutations in REC8 and OSD1. Through hybridization and offspring screening, plants with heterozygous mutations in both REC8 and OSD1 were obtained. In soybean variety Qihuang 34, EMS mutagenesis was used to screen offspring for heterozygous mutations in SPO11-1 and CENH3 genes. Through hybridization and offspring screening, plants with heterozygous mutations in both SPO11-1 and CENH3 were obtained. The plants with heterozygous mutations in REC8 and OSD1 were hybridized with plants with heterozygous mutations in both SPO11-1 and CENH3, and plants with heterozygous mutations in all four genes were obtained through screening.
[0376] 2. Construction of transgenic vectors
[0377] A binary vector was constructed to drive the expression of wild-type CENH3 by the EC1.2 gene promoter specifically expressed in oocytes. This vector was transformed into plants with heterozygous mutations in all four genes. In the self-pollinated progeny of these plants, single plants with homozygous mutations in REC8, OSD1, SPO11-1, and CENH3 genes and containing EC1.2::CENH3 transgenic components were identified and screened. The self-pollinated seeds from these plants were then harvested.
[0378] 3. Identify plants with fixed ploidy and genotype in the F1 generation.
[0379] 1) In the F1 generation plants, cell ploidy was screened using flow cytometry, and the selected plants had cell ploidy consistent with that of the parent plants.
[0380] The specific method is as follows:
[0381] Take a certain amount of plant tissue and place it in a glass culture dish. Add 1-2 ml of plant lysis buffer LB01 and chop it with a blade (this operation should always be performed on ice). Aspirate the lysis solution from the culture dish and filter it through a 50 μm nylon mesh into a centrifuge tube. Centrifuge at 1200 rpm and 4 °C for 5 min. Discard the supernatant and add 450 μl of LB01, 25 μL of pre-chilled PI (1 mg / ml), and RNase A (1 mg / ml). Stain in the dark for 10 min and then analyze the staining results to screen for diploid plants.
[0382] 2) Genotyping.
[0383] DNA was extracted from leaves of four randomly selected F1 plants with fixed ploidy and their parent plants. Sixteen heterozygous loci were randomly selected from the parent hybrids, and detection primers were designed. Genotyping of the F1 plants revealed that the genotypes of these four plants at the 16 loci were completely identical to those of the parent plant, indicating heterozygosity. This molecular biological evidence demonstrates that no recombination or segregation of the heterozygous genotype occurred.
[0384] Example 7
[0385] 1. In this embodiment, the F1 hybrid used is the maize hybrid Jiahe 158, which is formed by crossing LD140×LD975.
[0386] 2. Construction of multi-gene knockout vectors.
[0387] The main steps are as follows:
[0388] 1) Construction of a single target SK-gRNA:
[0389] The following four sites were selected as the sites for CRISPR-Cas9 gene editing system to knock out maize REC8, OSD1, PAIR1, and MTL (underlined PAM sequences):
[0390] ZmOSD1 gene knockout site (SEQ ID NO: 30): TCTGCCTGTACTGGAGTTATTGG
[0391] ZmPAIR1 gene knockout site (SEQ ID NO: 31): GGATTGCTGCGACAGCGGCTGGG
[0392] ZmREC8 gene knockout site (SEQ ID NO: 32): GGAAGTCCCACGAGTAATTATGG
[0393] ZmMTL gene knockout site (SEQ ID NO: 33): GGAAGGCGAGGATGGTTCCCGGG
[0394] 2) Concatenation of multiple gRNAs and construction of the final binary expression vector:
[0395] Utilizing the isosinetic nature of BglII and BamHI, NheI and XbaI, and SalI and XhoI, gRNA polymerization was performed: SK-gRNA ZmOSD1 was digested with KpnI and XhoI to serve as a vector; SK-gRNA ZmPAIR1 was digested with SalI and XbaI to provide the ZmPAIR1 sgRNA fragment; SK-gRNA ZmREC8 was digested with NheI and BamHI to provide the ZmREC8 sgRNA fragment; and SK-gRNA ZmMTL was digested with BglII and KpnI to provide the ZmMTL sgRNA fragment. This allowed for a one-step rapid polymerization of up to four gRNAs. Finally, the polymerized gRNAs ZmOSD1-gRNA, ZmREC8-gRNA, and ZmPAIR1-gRNA were synthesized. The ZmMTL fragment was digested with KpnI and BglII and the fragment was recovered. It was then ligated into the binary vector pC1300-Cas9 (between the KpnI and BamHI sites) that expresses the Cas9 protein, resulting in a multi-gene knockout vector pC1300-Cas9-gRNA ZmOSD1-gRNA ZmREC8-gRNA ZmPAIR1-gRNA ZmMTL that can simultaneously knock out four maize genes: REC8, OSD1, PAIR1, and MTL. This vector was used to prepare maize multi-mutant strains through transgenic production.
[0396] 3. Obtaining transgenic plants.
[0397] The maize multi-gene knockout vector obtained in the previous step was transferred into Agrobacterium tumefaciens strain LBA4404 via electroporation. This binary expression vector was then transferred into callus of maize hybrid Jiahe 158 using Agrobacterium-mediated transformation. After maize pollination, the ears were manually bagged for 9-12 days. The husks were removed from the female ears, and each layer of husk was sprayed with 75% alcohol for surface disinfection. Immature embryos (1.0-1.2 mm in size) were picked up under a clean bench and placed in a hyperosmotic solution for no more than one hour. When the Agrobacterium culture reached an OD600 of 0.8, the cells were collected by centrifugation and resuspended in a 1 mol / L suspension. Acetyleugenol was added to a final concentration of 200 μmol / L, and the embryos were infected with this solution for 5 minutes. The embryos were then transferred to a co-culture medium and incubated in the dark at 25°C for 7 days. The embryos were then transferred to a selection medium containing 15 mg / L hygromycin and a subsequent regeneration medium to screen for resistant callus and transgenic plants.
[0398] 4. Sequencing to identify the four mutants
[0399] Genomic DNA was extracted from transgenic maize plants using the CTAB method, and the mutation status of the target gene was identified using Hi-Tom (for details, please refer to CN201710504178.3).
[0400] 5. Identify maize plants with fixed ploidy and genotype in the F1 generation.
[0401] 1) Among the F1 plants of the identified four mutant maize, cell ploidy was screened by flow cytometry, and the selected plants had cell ploidy consistent with that of the parent plants.
[0402] The specific method is as follows:
[0403] Take a certain amount of plant tissue and place it in a glass culture dish. Add 1-2 ml of plant lysis buffer LB01 and chop it with a blade (this operation should always be performed on ice). Aspirate the lysis solution from the culture dish and filter it through a 50 μm nylon mesh into a centrifuge tube. Centrifuge at 1200 rpm and 4 °C for 5 min. Discard the supernatant and add 450 μl of LB01, 25 μL of pre-chilled PI (1 mg / ml), and RNase A (1 mg / ml). Stain in the dark for 10 min and then analyze the staining results to screen for diploid plants.
[0404] 2) Whole genome sequencing.
[0405] Leaves from two parents, LD140 and LD975, Jiahe 158, and F1 maize plants with fixed ploidy were selected, and DNA was extracted for whole-genome sequencing. The genotypes of the F1 maize plants were identical to those of Jiahe 158, indicating a heterozygous state, which, from a molecular biological perspective, proves that the genotypes are completely identical to those of the hybrid mother cells.
[0406] Example 8
[0407] 1. In this embodiment, the F1 hybrid used is the tomato hybrid Elisa, whose maternal parent is the low-temperature resistant inbred line “S2-4” and the paternal parent is the high-quality disease-resistant inbred line “S28”.
[0408] 2. Construction of multi-gene knockout vectors.
[0409] The main steps are as follows:
[0410] 1) Construction of a single target SK-gRNA:
[0411] The following four sites were selected as the sites for CRISPR-Cas9 gene editing system to knock out REC8, OSD1, SpO11, and MTL in tomatoes (underlined PAM sequences):
[0412] SlOSD1 gene knockout site (SEQ ID NO: 34): CAGAAGCAGGGAGAATGGCAGG
[0413] SlSPO11 gene knockout site (SEQ ID NO: 35): TGAGGATCTCGCTCGAGGTAGG
[0414] SlREC8 gene knockout site (SEQ ID NO: 36): GCACAGGAGGAACCTGCTAAGG
[0415] SlMTL gene knockout site (SEQ ID NO: 37): TGATTGCCGGAACGAGCACCGG
[0416] 2) Concatenation of multiple gRNAs and construction of the final binary expression vector:
[0417] Utilizing the isosinetic properties of BglII and BamHI, NheI and XbaI, and SalI and XhoI, gRNA polymerization was performed: SK-gRNA SlOSD1 was digested with KpnI and XhoI to serve as a vector; SK-gRNA SlSPO11 was digested with SalI and XbaI to provide the SlSPO11 sgRNA fragment; SK-gRNA SlREC8 was digested with NheI and BamHI to provide the SlREC8 sgRNA fragment; and SK-gRNA SlMTL was digested with BglII and KpnI to provide the SlMTL sgRNA fragment. This allowed for a one-step rapid polymerization of up to four gRNAs. Finally, the polymerized gRNAs SlOSD1-gRNA, SlREC8-gRNA, and SlPAIR1-gRNA were synthesized. The SlMTL fragment was digested with KpnI and BglII and the fragment was recovered and ligated into the binary vector pC1300-Cas9 (between the KpnI and BamHI sites) expressing the Cas9 protein. The result was a multi-gene knockout vector pC1300-Cas9-gRNA SlOSD1-gRNA SlREC8-gRNA SlSPO11-gRNA SlMTL that can simultaneously knock out four genes in tomato: REC8, OSD1, SPO11, and MTL. This vector was used to prepare multiple mutant tomatoes through transgenic production.
[0418] 3. Obtaining transgenic plants.
[0419] The tomato multi-gene knockout vector obtained in the previous step was transferred into Agrobacterium strain EHA105 by electroporation using the leaf disc method. Then, this binary expression vector was transferred into the callus of the tomato hybrid Elisa using the Agrobacterium-mediated transformation method.
[0420] Tomato seeds were aseptically treated and sown on 1 / 2 MS medium. After germination in the dark for 2-3 days, they were cultured under light. After 10-12 days, when the cotyledons of the seedlings were fully expanded but no true leaves had yet formed, the cotyledons were selected as explants. Both ends of the cotyledons were removed, and the middle part was divided horizontally in half to form leaf discs. The leaf discs were inoculated into a pre-culture medium with the leaf surface facing up and pre-cultured for 2 days. The pre-cultured cotyledon leaf discs were then soaked in a prepared Agrobacterium solution for 5 minutes, and then the leaf discs were blotted dry with sterile filter paper. The leaf discs were then placed with the leaf surface facing up and cultured in the dark for 48-72 hours at 28℃. The leaf discs co-cultured with Agrobacterium were then transferred to a sterile culture medium and cultured under light. After 5 days, the leaf discs were transferred to a selection medium, and this process was repeated every 14 days. When the resistant shoots reached about 2 cm in length, they were cut from the explants and transferred to a rooting medium. After the root system was well developed, the seedlings were transplanted into the soil.
[0421] 4. Sequencing to identify the four mutants
[0422] Genomic DNA was extracted from transgenic tomatoes using the CTAB method, and the mutation status of the target gene was identified using Hi-Tom (for details, please refer to CN201710504178.3).
[0423] 5. Identify tomato plants with fixed ploidy and genotype in the F1 generation.
[0424] 1) Among the F1 plants of the identified four mutant tomatoes, cell ploidy was screened by flow cytometry, and the selected plants had cell ploidy consistent with that of the parent plants.
[0425] The specific method is as follows:
[0426] Take a certain amount of plant tissue and place it in a glass culture dish. Add 1-2 ml of plant lysis buffer LB01 and chop it with a blade (this operation should always be performed on ice). Aspirate the lysis solution from the culture dish and filter it through a 50 μm nylon mesh into a centrifuge tube. Centrifuge at 1200 rpm and 4 °C for 5 min. Discard the supernatant and add 450 μl of LB01, 25 μL of pre-chilled PI (1 mg / ml), and RNase A (1 mg / ml). Stain in the dark for 10 min and then analyze the staining results to screen for diploid plants.
[0427] 2) Whole genome sequencing.
[0428] DNA was extracted from leaves of two parental lines, "S2-4" and "S28," the tomato hybrid Elisa, and F1 generation tomato plants with fixed ploidy, and whole-genome sequencing was performed. The genotypes of the F1 generation tomato plants were identical to those of Elisa, indicating a heterozygous state, which, from a molecular biological perspective, proves that the genotypes are completely identical to those of the hybrid mother cells.
[0429] In addition, all carriers and reagents used in this embodiment are included in the kit of this embodiment.
[0430] The above description is merely a preferred embodiment of the present invention and is not intended to limit the invention. Various modifications and variations can be made to the present invention by those skilled in the art. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of the present invention should be included within the scope of protection of the present invention.
Claims
1. A method for maintaining heterosis in plants, characterized in that, Includes the following steps: S1, using gene mutation or genetic engineering technology to transform the meiotic division of the reproductive cells of hybrids into a mitotic-like process, thereby obtaining gametes that are consistent with the genotype and chromosome ploidy of the hybrids; as well as S2 utilizes gene mutation and genetic engineering techniques to influence the development of plant gametes or embryos, and the protein involved is the MTL protein.
2. The method according to claim 1, characterized in that, The gene mutations include random mutagenesis and directed mutagenesis; wherein, the random mutagenesis includes chemical mutagenesis, physical mutagenesis, and biological mutagenesis; the directed mutagenesis includes gene editing technology, including CRISPR / Cas gene editing technology, CRISPR / Cpf1 gene editing technology, TALEN gene editing technology, homing endonuclease gene editing technology, and ZFN gene editing technology; the genetic engineering technology includes transgenic technology to induce specific expression, translocation expression, or gene silencing of genes.
3. The method according to claim 1, characterized in that, S1 includes taking a hybrid and using gene mutation or genetic engineering technology to transform the meiotic division of its germ cells into a mitotic-like process, thereby obtaining gametes with the same genotype and chromosome ploidy as the hybrid.
4. The method according to claim 1, characterized in that, S1 includes editing the parents of the hybrid using gene mutation or genetic engineering technology, then obtaining the hybrid through hybridization between the parents, and then obtaining hybrid gametes that transform germ cells into meiotic cells similar to mitosis.
5. The method according to claim 1, characterized in that, S1 includes using gene mutation or genetic engineering techniques to edit proteins involved in meiosis in plants to transform meiosis in germ cells into a mitotic-like process; wherein the proteins include a first protein, a second protein, and a third protein, wherein, The first protein is a protein involved in the formation of DNA double-strand breaks, and the first protein is selected from the following proteins: Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PAIR1 protein, such as the PAIR1 protein shown in SEQ ID NO:13; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PAIR1 protein. Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PAIR2 protein, such as the PAIR2 protein shown in SEQ ID NO:14; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PAIR2 protein. Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PAIR3 protein, such as the PAIR3 protein shown in SEQ ID NO:15; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PAIR3 protein. Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD1 protein, such as the PRD1 protein shown in SEQ ID NO:16; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD1 protein. Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD2 protein, such as the PRD2 protein shown in SEQ ID NO:17; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD2 protein. Proteins such as the SPO11-1 protein shown in SEQ ID NO:18, proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-1 protein, or proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-1 protein; Proteins such as the SPO11-2 protein shown in SEQ ID NO:19, proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-2 protein, or proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-2 protein; Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SDS protein, such as the SDS protein shown in SEQ ID NO:20; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SDS protein. Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the CRC1 protein, such as the CRC1 protein shown in SEQ ID NO:21; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the CRC1 protein. P31 as shown in SEQ ID NO:22 comet Protein, with the aforementioned P31 comet Proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence identity, or proteins that are identical to P31. comet Proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity; Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTOPVIB protein, such as the MTOPVIB protein shown in SEQ ID NO:23; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTOPVIB protein. The DFO protein as shown in SEQ ID NO:24, and a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the DFO protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the DFO protein; The second protein is involved in controlling the adhesion between sister chromosomes during meiosis, and the second protein is selected from the following proteins: Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the REC8 protein, such as the REC8 protein shown in SEQ ID NO:25; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the REC8 protein. The third protein participates in the second meiotic division, and the third protein is selected from the following proteins: Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the OSD1 protein, such as the OSD1 protein shown in SEQ ID NO:26; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the OSD1 protein. Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TAM protein, such as the TAM protein shown in SEQ ID NO:27; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TAM protein. Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TDM1 protein, such as the TDM1 protein shown in SEQ ID NO:28, or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TDM1 protein.
6. The method according to claim 1, characterized in that, The S2 includes using gene mutation and genetic engineering techniques to influence the process of plant gamete or embryo development, inducing the gamete to develop into a seed or plant.
7. The method according to claim 6, characterized in that, The S2 includes inducing the gametes to develop into seeds or plants by presenting them with induced pollen from other plants.
8. The method according to claim 1, characterized in that, The S2 includes inducing the gametes to develop into seeds or plants through physical stimulation, biological stress, or chemical treatment.
9. The method according to claim 1, characterized in that, The S2 includes inducing the gametes to develop into seeds or plants through anther culture or pollen culture.
10. The method according to claim 6, characterized in that, The MTL protein is the MTL protein shown in SEQ ID NO:29, or a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTL protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTL protein.
11. The method according to claim 1, characterized in that, The plants include monocotyledons and dicotyledons.
12. The method according to claim 1, characterized in that, The plants mentioned include rice, corn, sorghum, millet, barley, wheat, rye, oats, buckwheat, Job's tears, sugarcane, asparagus, bamboo shoots, leeks, yams, soybeans, potatoes, peas, mung beans, adzuki beans, broad beans, cowpeas, kidney beans, lentils, mandarins, chickpeas, cassava, sweet potatoes, rapeseed, cotton, beets, eggplant, peanuts, tea, mint, coffee, sesame, sunflower, castor beans, perilla seeds, safflower, tomatoes, peppers, cucumbers, bok choy, lettuce, spinach, garlic, cabbage, mustard greens, water chestnuts, scallions, winter melon, zucchini, loofah, Chinese cabbage, radishes, onions, watermelons, grapes, carrots, cauliflower, pumpkins, tobacco, forage grass, elephant grass, foxtail grass, Sudan grass, orchids, lilies, tulips, and alfalfa.
13. A plant or seed that retains heterosis, characterized in that, It is prepared by the method described in any one of claims 1 to 11.
14. A kit for maintaining heterosis in plants using the method of claim 1, characterized in that, The kit includes a carrier and / or reagent that enables meiosis in plant reproductive cells to be converted into mitosis-like processes, and a carrier and / or reagent that enables gametes to develop into seeds or plants.
15. The kit according to claim 14, characterized in that, The carrier and / or reagent that enables the meiosis of plant reproductive cells to be transformed into a mitosis-like process is a carrier and / or reagent that transforms the meiosis of hybrid reproductive cells into a mitosis-like process through gene mutation or genetic engineering technology, preferably a carrier and / or reagent that is subject to random mutagenesis or directed mutagenesis.
16. The reagent kit according to claim 15, characterized in that, The random mutagenesis includes chemical mutagenesis, physical mutagenesis, and biological mutagenesis; the directed mutagenesis includes CRISPR / Cas gene editing technology, CRISPR / Cpf1 gene editing technology, TALEN gene editing technology, homing endonuclease gene editing technology, and ZFN gene editing technology; the genetic engineering technology includes transgenic technology to induce specific expression, translocation expression, or gene silencing of genes.
17. The kit according to claim 14, characterized in that, The vector and / or reagent capable of transforming meiosis in plant reproductive cells into a mitosis-like process is a vector and / or reagent that utilizes gene mutation or genetic engineering techniques to edit proteins involved in meiosis in plants to achieve this transformation. The proteins include a first protein, a second protein, and a third protein. The first protein is involved in the formation of DNA double-strand breaks, and the first protein is selected from the following proteins: Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PAIR1 protein, such as the PAIR1 protein shown in SEQ ID NO:13; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PAIR1 protein. Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PAIR2 protein, such as the PAIR2 protein shown in SEQ ID NO:14; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PAIR2 protein. Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PAIR3 protein, such as the PAIR3 protein shown in SEQ ID NO:15; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PAIR3 protein. Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD1 protein, such as the PRD1 protein shown in SEQ ID NO:16; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD1 protein. Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD2 protein, such as the PRD2 protein shown in SEQ ID NO:17; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD2 protein. Proteins such as the SpO11-1 protein shown in SEQ ID NO:18, proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SpO11-1 protein, or proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SpO11-1 protein; Proteins such as the SPO11-2 protein shown in SEQ ID NO:19, proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-2 protein, or proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-2 protein; Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SDS protein, such as the SDS protein shown in SEQ ID NO:20; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SDS protein. Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the CRC1 protein, such as the CRC1 protein shown in SEQ ID NO:21; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the CRC1 protein. P31 as shown in SEQ ID NO:22 comet Protein, with the aforementioned P31 comet Proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence identity, or proteins that are identical to P31. comet Proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity; Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTOPVIB protein, such as the MTOPVIB protein shown in SEQ ID NO:23; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTOPVIB protein. The DFO protein as shown in SEQ ID NO:24, and a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the DFO protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the DFO protein; The second protein is involved in controlling the adhesion between sister chromosomes during meiosis, and the second protein is selected from the following proteins: Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the REC8 protein, such as the REC8 protein shown in SEQ ID NO:25; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the REC8 protein. The third protein participates in the second meiotic division, and the third protein is selected from the following proteins: Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the OSD1 protein, such as the OSD1 protein shown in SEQ ID NO:26; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the OSD1 protein. Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TAM protein, such as the TAM protein shown in SEQ ID NO:27; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TAM protein. Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TDM1 protein, such as the TDM1 protein shown in SEQ ID NO:28, or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TDM1 protein.
18. The kit according to claim 14, characterized in that, The carriers and / or reagents for inducing gametes to develop into seeds or plants include carriers and / or reagents for inducing gamete development into seeds or plants by influencing MTL proteins involved in the development of plant gametes or embryos using gene mutations or genetic engineering techniques. The MTL protein is the MTL protein shown in SEQ ID NO:29, or a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTL protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTL protein.
19. A plant produced using the kit according to any one of claims 14 to 18, characterized in that, The plant's reproductive cells undergo meiosis, transforming into a mitotic-like process that produces gametes with the same genotype and chromosome ploidy as the hybrid.
20. The plant according to claim 19, characterized in that, The gametes of the plant can be induced to develop into plants or seeds.
21. The plant according to claim 20, characterized in that, The plant is a genetically mutated or genetically engineered plant. The plant is modified by using gene mutation or genetic engineering techniques to regulate proteins involved in meiosis, thereby transforming meiosis in reproductive cells into a mitotic-like process. It is also modified by using gene mutation or genetic engineering techniques to influence a fourth protein involved in gamete or embryo development, inducing gametes to develop into seeds or plants. The proteins include a first protein, a second protein, and a third protein. The first protein is involved in the formation of DNA double-strand breaks, and the first protein is selected from the following proteins: Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PAIR1 protein, such as the PAIR1 protein shown in SEQ ID NO:13; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PAIR1 protein. Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PAIR2 protein, such as the PAIR2 protein shown in SEQ ID NO:14; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PAIR2 protein. Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PAIR3 protein, such as the PAIR3 protein shown in SEQ ID NO:15; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PAIR3 protein. Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD1 protein, such as the PRD1 protein shown in SEQ ID NO:16; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD1 protein. Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD2 protein, such as the PRD2 protein shown in SEQ ID NO:17; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the PRD2 protein. Proteins such as the SpO11-1 protein shown in SEQ ID NO:18, proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SpO11-1 protein, or proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SpO11-1 protein; Proteins such as the SPO11-2 protein shown in SEQ ID NO:19, proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-2 protein, or proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SPO11-2 protein; Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SDS protein, such as the SDS protein shown in SEQ ID NO:20; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the SDS protein. Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the CRC1 protein, such as the CRC1 protein shown in SEQ ID NO:21; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the CRC1 protein. Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the P31comet protein, such as the P31comet protein shown in SEQ ID NO:22; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the P31comet protein. Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTOPVIB protein, such as the MTOPVIB protein shown in SEQ ID NO:23; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTOPVIB protein. The DFO protein as shown in SEQ ID NO:24, and a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the DFO protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the DFO protein; The second protein is involved in controlling the adhesion between sister chromosomes during meiosis, and the second protein is selected from the following proteins: Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the REC8 protein, such as the REC8 protein shown in SEQ ID NO:25; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the REC8 protein. The third protein participates in the second meiotic division, and the third protein is selected from the following proteins: Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the OSD1 protein, such as the OSD1 protein shown in SEQ ID NO:26; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the OSD1 protein. Proteins having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TAM protein, as shown in SEQ ID NO:27; or proteins having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TAM protein; as shown in SEQ ID NO:
27. The TDM1 protein shown in NO:28, a protein having at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TDM1 protein, or a protein having at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TDM1 protein; Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TDM1 protein, such as the TDM1 protein shown in SEQ ID NO:28; or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the TDM1 protein. The fourth protein is selected from the following proteins: Proteins that have at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTL protein, such as the MTL protein shown in SEQ ID NO:29, or proteins that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 98% sequence similarity to the MTL protein.
22. A method for maintaining heterosis in plants, characterized in that, Includes the following steps: S1, using gene editing technology to transform the meiotic division of the germ cells of hybrids in the F1 generation into a mitotic-like process, thereby obtaining diploid female gametes in the F1 generation; as well as S2, using gene mutation and genetic engineering techniques to influence the development of plant gametes or embryos and induce the diploid female gametes to develop into seeds, wherein the protein involved is the MTL protein.
23. The method according to claim 22, characterized in that, S1 includes taking F1 generation hybrid seeds and using gene editing technology to transform the meiotic division of germ cells into a mitotic-like process to obtain F1 generation diploid female gametes.
24. The method according to claim 22, characterized in that, S1 includes using gene editing technology to edit the parents of the hybrid to obtain plants in which all edited genes are heterozygous mutations, then obtaining hybrids by crossing the parents, screening the hybrids for plants in which multiple edited genes in both parents are homozygous mutations, and then obtaining diploid female gametes of the F1 generation that undergo meiosis similar to mitosis.
25. The method according to claim 23 or 24, characterized in that, S1 includes using gene editing technology to knock out the REC8, OSD1, and PAIR1 genes to transform meiosis in germ cells into a mitotic-like process.
26. The method according to claim 22, characterized in that, S2 includes inducing the diploid female gamete to develop into a seed by giving it pollen from a haploid inducing line.
27. The method according to claim 26, characterized in that, S2 includes generating haploid inducible pollen lines by knocking out the MTL gene using gene editing technology.
28. The method according to claim 26, characterized in that, The S2 includes inducing the diploid female gametes to develop into seeds using pollen from haploid inducing lines of other plants.
29. The method according to claim 25, characterized in that, The hybrid strain had the REC8, OSD1, PAIR1, and MTL genes simultaneously knocked out in the F1 generation.
30. The method according to claim 22, characterized in that, The plants mentioned include rice, corn, sorghum, millet, barley, and wheat.
